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Chemistry

Synthesis o f conformationally constrained glutamate analogues and their preliminary
evaluation as glutamate transport inhibitors
Director: Charles M. Thompson (JM /
The primary goals o f the research effort were to assess the reactivity of dimethyl 4oxoglutaconate in the normal electron demand Diels-Alder reaction. Once the Diels-Alder
reaction was deemed a success, the adducts were transformed into conformationally
constrained analogues o f 2-oxoglutarate by saponification. The cyclic 2-oxoglutarate
analogues were evaluated as substrates and inhibitors of a number of transaminases and
dehydrogenases. One transaminase was found to convert the oxoglutarate analogues to
glutamate analogues. The Diels-Alder adducts were also chemically transformed into
conformationally constrained analogues of glutamate by preliminary formation of the
corresponding N, N-dimethylhydrazones and subsequent reduction with sodium hydrosulfite
and saponification. The glutamate analogues were tested at four glutamate transporters and
two compounds, namely 6-(amino-carboxy-methyl)-cyclohex-3-enecarboxylic acid and 3(amino-carboxy-methyl)-bicyclo[2.2.2]oct-5-ene-2-carboxylic acid, 38 ± 2 and 35 ± 5
percent o f control, respectively, were found to be potent and selective inhibitors o f the
excitatory amino acid transporter 2 (EAAT2).
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C hapter l:O vervtew of the Glutam ate Neurosystem

I. Glutam ate as a Neurotransm itter

L-Glutamate (Figure 1.1) is an excitatory amino acid (EAA) that is responsible for
neuronal signaling in the mammalian central nervous system (CNS). Immunostaining
has revealed the involvement of L -glutamate utilizing proteins in optic nerve terminals
and terminals o f the cortico-fugal axons in the
+

thalamus (Salt, 1996; Kechagias, 1995) as well
as the hippocampus, medial striatum, and cortex

Figure 1.1. Structure o f L-glutamate

regions o f the brain (Cotman, 1995). Excitatory
amino acids regulate the stimulation of the
postsynaptic terminal o f neurons by mediating

changes in electric potential (caused by a flow o f charged ions, i.e., Na+, Ca’"r and 1C).
The involvement of glutamate as an EAA ranges from participation in excitatory
neurotransmission to memory to neuropathology. Neuronal signaling is highly dependent
on the transport and metabolism o f neurotransmitters. The most common signal
termination pathways being either enzymatic conversion to a non-transmissible
compound or transport o f the neurotransmitters back out o f the synaptic cleft by
neurotransmitter transporters. The glutamate neurosystem follows the latter mechanism.
Neurotransmitter signaling can also be directly affected by agonists and/or antagonists
interacting at the receptors or transporters, which will affect the associated biological
response.
1
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The receptors, transporters, and enzymes that bind L-glutamate during the process o f
excitatory neurotransmission comprise one o f the most diverse and broadly functional
protein groups in the mammalian central nervous system (Cotman, 1995). L -Glutamate
(Figure 1.1) is a conformationally flexible molecule containing three distinct functional
groups. Owing to the three sp3 hybridized carbons in its structure, L -glutamate can exist
in nine low energy conformations. The pKa's o f the acidic and basic functional groups o f
L-glutamate play an important role in the overall chemistry o f the molecule and must be
considered: pKa (a-C02H) = 2.10; pKa (a-NH 3^) = 9.47; and pKa (S-CO^H) = 4.07
(Carrigan, 1999). At physiological pH, L-glutamate is completely ionized and has a net
charge o f -1. These pKa characteristics play an important role upon binding to various
receptors, transporters, and enzymes.
Within the glutamate pre-synaptic neuron, the glutamate molecules exist in the
cell cytosol at a concentration of 1-3 mM (Arriza, 1994). From the cytosol, glutamate is
transported and packaged into synaptic vesicles where it is stored until the signaling
event arrives (Figure 1.2) (Naito, 1985). Upon nerve stimulation, the vesicles are
transported via fusion proteins (Cousin, 1999; Betz, 1994) to the pre-synaptic nerve
terminal where they dock and release glutamate in a calcium-dependent manner into the
synaptic cleft. Once glutamate is released into the cleft, it freely binds to various postsynaptic receptors and therefore, enables signals to be potentiated. The post synaptic
EAA receptors can be placed into two groups: (a) the metabotropic receptors (where
activation leads to the generation o f a cascade o f second messengers) and (b) the
ionotropic receptors (where activation leads to opening o f ion channels which gate Na~-,

2
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K+-, and Ca**- currents) (Monaghan, 1986). It is hypothesized that glutamate may bind
and trigger unique responses at the corresponding

3
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:

Figve 12 EAA Synapse
This figure was graciously donated by Richard J. Bridges of the University o f Montana
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receptors through its distinct conformations (Chamberlin, 1993). Once L-glutamate binds
to the individual receptors and induces a signal, the high concentrations (1-10 pM) o f L glutamate must be cleared from the synaptic cleft and returned to the pre-synaptic neuron
(Bridges, 1994; Garlin, 199S). The clearance o f glutamate from the synaptic cleft is
accomplished by high-affinity glutamate transporters. There are two groups o f “high
affinity” transporters currently classified: (a) synaptosomal transporters (those which
directly transport glutamate back to the presynaptic cytosol where it can be taken up by
vesicles), or (b) astroglial transporters (those which relocate glutamate from the synapse
into astrocytes). Once in astrocytes glutamate is concurrently transformed into glutamine
via glutamine synthetase (Figure 1.2) (Cotman, 1995). Glutamine is not an excitatory
amino acid and is thus rendered inactive to post synaptic receptors and, in turn, may be
transported back to the presynaptic neuron via transporters specific for glutamine
(Chaudhry, 1999). Once the glutamine is relocated to the presynaptic neuron it is
enzymatically converted back into glutamate by glutaminase. The glutamate is
subsequently transported back into synaptic vesicles to await the next excitatory impulse.
L-Glutamate neurotransmission has critical impact on numerous biochemical
processes (Cotman, 1995). In addition to mediating fast excitatory synaptic signaling,
glutamate receptor activation participates in higher-order processes, such as development,
learning and memory. L-Glutamate is also involved in neuropathology, as excessive
stimulation o f the post-synaptic neuron by excitatory amino acids trigger events which
can lead to cell death (Rothman, 1995; Choi, 1988). This process, referred to as
excitotoxicity, is thought to play a role in a number o f neurological insults and diseases

5
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including ischemia, stroke, anoxia, hypoglycemia, epilepsy, Huntington’s disease, and
Alzheimer’s disease (Rothman, 1995).
The focus o f most of the L-glutamate EAA pharmacology over the last decade has
resided in two areas: (1) differentiating the pharmacology o f the ligand binding sites to
the various EAA receptors and transporters, and (2) cDNA expression and structural
studies o f the receptors and transporters (Cotman, 1995). Major advances in the
pharmacology of glutamate binding sites has been added by the design and synthesis of
conformationally restricted and isosterically similar analogues o f L-glutamate o f which
mimic low energy conformations exist (Figure 1.3) (Chamberlin, 1993). These analogues
have provided key information about the receptor types and the three dimensional
pharmacophore models o f the receptor and transporter binding sites. These analogues
have also played a pivotal role in differentiating the structure and function o f the various
receptors and transporters.
The study and design o f conformationally restricted analogues o f L-glutamate
have led to selective and potent analogues which bind to and differentiate the receptor
and transporter substrate binding sites. N-Methyl-D-aspartate (NMDA), (RS)-2-amino(3-hydroxyl-5-methyl-4-isoxazol-4-yl) propionic acid (AMPA), and kainic acid (KA) are
conformationally restricted and isosterically related analogues o f L-glutamate which were
used to identify and distinguish the ionotropic L-glutamate receptors. The glutamate
analogues, 1-aminocyclopentane-trans-1,3-dicarboxylate (trans-ACPD) and L-2-amino-4phosphonobutyrate (L-AP4) were the lead compounds (Salt, 1996; Cotman, 1995) in
defining the pharmacology and function o f the metabotropic L-glutamate receptors
(mGluR’s) (Conn, 1997). Several families o f analogues have proven valuable in
6
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f ^ ) —C 02H
N

H

N-methyl-D-aspartate

kainic acid
NMDA
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H02Cy - v

ch3

h o 2 c.
r

h^

y

^

c

' C02H

trans 1 -aminocyclopentane1,3-dicarboxylic acid

(RS) 2-amino-3-(3-hydroxy-5methylisoxazol-4-yl)propionic acid

ACPD

AMPA

Figure 13. Examples o f structurally constrained and unconstrained agents patterned
after L-glutamate utilized in characterizing the glutamate receptors

characterizing the high-affinity, sodium dependent excitatory amino acid transporters
(EAATs) that mediate the majority o f glutamate uptake in the CNS, including: 2,4pyrrolidinedicarboxylic acids (2,4-PDCs), 2-(carboxycyclopropyl)glycines (l-CCG -IIV), f3-hydroxyaspartate derivatives, methyl-substituted glutamate analogues, and
oxazoline-based derivatives (Bridges, 1991; Chamberlin, 1998; Shimamoto, 1991). In
particular, the conformationally restricted PDC- and CCG-based mimics are locked into
specific configurations at the substituent sites C3 and/or C4 (Figure 1.4) (Bridges, 1991;
Chamberlin, 1998; Shimamoto, 1991). Transport assays have demonstrated that L-trans-

7
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2,4-PDC acts as a substrate o f the excitatory amino acid transporter subtypes EAAT1-4
and as a non-substrate inhibitor o f the EAAT5 subtype (Arriza, 1997; 1994; Fairman,

H02C ^ < P C 0 2H
H

H

L-CCG-II

L-CCG-III

L-2-(carboxycyclopropyl)glycine II

L-2-(carboxycyclopropyl)glycine III

ho 2c *.

>—c o 2h
N
H
2,4-PDC
L-CCG-IV

L-trans 2,4-pyrrolidinedicarboxylic acid

L-2-(carboxycyclopropyl)glycine IV

Figure 1.4. Structurally constrained analogues o f L-glutamate utilized in characterizing
the EAATs

199S; Koch, 1999). Similarly, the individual stereoisomers o f the l-CCG s also exhibit
interesting activities at these transporters. For example, l-CCG-Q and L-CCG-m (Figure
1.4) have both been reported to block the uptake o f [3H]- L-glutamate into synaptosomal
preparations (Robinson, 1993). More detailed studies using cellular expression systems
have demonstrated that l-CCG-III potently inhibits EAAT1, EAAT2, and EAAT3, while
l-CCG-IV

preferentially inhibits EAAT2 (Shimamoto, 1998; Yamashita, 1995).

The analogues described either mimic L-glutamate with structural locking o f the
backbone into specific orientations or utilize a functional group isostere (a substituted
group which exhibits similar but unique characteristics and/or properties to the original
functional group which may affect binding affinities). The affinities o f these analogues
8
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Figure 1.5. Overlay o f L -CCG-II and R, R-3,4-(4,5-cyclohexenyl)-L-glutamate
rendered in PC Spartan Pro The numerical values from PC Spartan Pro for L -CCG-II
was -40.88 and for R, R-3,4-(4,5-cyclohexenyl)-L-glutamate was -6.26

to bind to various receptors and transporters are likely influenced by the relative positions
o f the charged functional groups and orientation o f the hydrocarbon backbone as
evidenced by the structurally diverse L-glutamate analogues (Figures 1.3 and 1.4)
(Chamberlin, 1993).
It is our goal to investigate cyclohexenyl locked analogues as glutamate mimics
resembling 2 ,4-PDC and the L-CCGs. A minimized molecular modeling rendition
performed in PC Spartan Pro (Version 1.0.5, Irvine CA) is provided in Figure 1.5. It is
9

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

shown that the glutamate backbone in both l-CCG-II and the 3 ,4-(4,5-cyclohexenyl)- l glutamate (one o f our theoretical targets, Figure 1.3) overlay very well.
The fact that the molecules overlay well is key preliminary data promoting the synthesis
of a new class of analogues for the study o f the glutamate neurosystem. It can be
predicted, by the modeling overlays, that at least one of the stereoisomers o f 3,4-(4,5cyclohexenyl)-D/ L -glutamates should show some activity at a transporter or receptor in
the glutamate

H f* 2

xY
x^

' t c°2H
T

' c o 2h

3,4-cyclohexenyl-fused
glutamate; X = H, alkyl, etc.

H

iTyi

x

c02H

xT

H ,C°2 h

T »

^ T - C O jH
3,4-cyclohexenyl-fused
glutamate; Y = CH2, CH2 CH2, etc.

3,4-cyclohexenyl-fused
pyroglutamate; X = H, alkyl, etc.

Figure 1.6: Proposed target 3,4-(4,5-cyclohexenyl)-D/L- glutamate molecules

neurosystem. It has been shown by Robinson and co-workers (1993) that l-CCG-Q
inhibits glutamate uptake in crude synaptasomes (presynaptic neuronal transport,
EAAT2) from rat cerebellum. With this data as groundwork, as well as the good overlay
o f the glutamate backbones o f l -CCG-II and the 3,4-(4,5-cyclohexenyl)-L-glutamate
shown in figure 1.6, it was decided to synthesize the 3,4-(4,5-cyclohexenyl)-D/Lglutamates which are good initial targets to explore as inhibitors at various transporters o f
the glutamate neurosystem, including EAAT2.
The various glutamate receptors and transporters tolerate a range o f chemical
variation, and perhaps these tolerances can be exploited in identifying a new class of
10
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compounds whose structures can be attenuated and tailored for specific or multi-receptor
/ transporter binding.
Our approach to further elucidate the stereochemical binding requirements of the
transporters o f the L-glutamate neurosystem is to conformationally lock the structure of
the L -glutamate molecule about the 3 ,4 position utilizing a cyclohexenyl moiety. This
hypothesis, to increase the size of the conformational locking group relative to the l-CCG
compounds referred to above, may further help delineate the critical regions o f space and
the structural elements o f ligands must occupy to interact with specific transporters o f the
glutamate neurosystem. Again, Figure 1.6 shows some representative examples of the
types o f molecules that are envisioned to further delineate the three-dimensional
specificities of the transport binding sites. The design and chemical synthesis of this
structural class o f molecules, their intermediate structures and the biological implications
o f the products will be discussed in the following chapters.

11
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C hapter 2: Organic Synthesis

I. Introduction

Our development of the 3 ,4-conformationally restricted analogues o f L-glutamate
is based on the retrosynthetic analysis depicted in Figure 2.1. The key o f the design is the
Diels-Alder reaction between dimethyl-4-oxoglutaconate. Once the adducts are accessed

NH2
' C 0 2H
4 C 0 2H
L-glutam ate

X ' i X ' C O ’H
>v /

x o 2h

^— ^

2.1: 3,4-conform ationally
restricted glutam ate

xC

:

c o 2h

2.2: 3,4-conform ation ally
restricted oxoglutarate

c o 2ch 3
h3co 2c

2 J dim ethyl 4-oxoglu tacon ate
(D O G )

Figure 2.1: Retrosynthetic disconnection scheme towards 3,4-conformationally
restricted glutamates

a chemical or enzymatic reductive amination was conceived to introduce the alpha-amino
moiety.
One key feature o f the synthesis is the need to develop o f a multigram synthesis
o f the key intermediate, dimethyl 4-oxoglutaconate (DOG, 2.3). The synthesis o f the
14
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ethyl analogue of DOG was first prepared by Comforth et. al. by the oxidation o f diethyl
glutaconate with selenium dioxide (Comforth, 1946). The percent yield was reported as
2% and the molecule was characterized by boiling point, elemental analysis and
UV/visible spectroscopy. In 1981, an alternate route for the synthesis o f DOG was
disseminated by Corey and co workers (Corey, 1981). The synthesis described is shown
in Figure 2.2, although only the general experimental procedure was reported.

O
SOCI2
CH3 OH *

ho 2c

2 .4 2 -o x o g lu ta n c acid

r'X O zC H a

Br2

h 3 c o 2c

c h 2 ci 2

2.5: D im ethyl 2-oxoglutarate

O
* s A c o 2ch 3
H3 C 02C

TEA
Et20

c o 2ch 3
H3 C 02C
23 D im ethyl 4-oxog lu ta co n a te

2.6: D im ethyl 3-b rom o-2oxoglutarate

(D O G )

Figure 2.2: Synthesis o f DOG (2.3)

In 1987, it was discovered by Ananda, et. al. that the oxidation o f dimethyl
glutaconate with activated carbon could generate DOG in modest yields (Ananda, 1987).
In this report, DOG was characterized by lH NMR for the olefinic protons, melting point
and UV/visible spectroscopy. In 1996, a detailed analysis of the l3C NMR spectra of
DOG in organic and aqueous media was performed by Kato and co workers (Kato, 1996).

15
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The authors reported that the molecule could be purchased from Fluka Chemical
Company (Buchs, Switzerland), but it is no longer available.
Taken together, DOG has been characterized by its spectroscopic and physical
properties, but a reliable, concise chemical synthesis with detailed spectral data for the
individual steps had yet to be performed. Carrigan (1999) reported a multigram synthesis
o f DOG from readily available starting materials in modest yield, according to the
original sequence reported by Corey (1981) (Figure 2.2). In the following sections we
will report our synthesis o f DOG on a multigram scale and it’s utilization in chemical
reactions with detailed spectral interpretation of the products and key chemical
intermediates.
The Diels-Alder reaction is a fundamental carbon-carbon bond forming reaction
in synthetic organic chemistry (DeGraw, 1960; Tokoroyama, 1978; Danishefsky, 1979;
Snowden, 1986; Grieco, 1990). It is synonymously termed a [4+2]-cycloaddition
reaction in reference to the formation of a cyclic system upon reaction o f a 4rc-electron
system with a 2rc-electron system (Carey, 1984). The products formed are typically
referred to as cycioadducts and the significance o f this reaction in organic chemistry
owes to the fact that two carbon-carbon bonds are formed and the reaction is very highly
regio- and stereoselective. Experimental data supports the premise that the reaction
occurs via a concerted mechanism. The stereoselective syn products resulting from this
reaction strengthen this argument. If it were to occur in a stepwise mechanism, the 2nd
addition step would have to occur at a rate faster than that o f a rotation about a carboncarbon bond, which is not likely.

16
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The Diels-Alder reaction is also under stereo- and regioselective control in a
number o f ways. First, in the construction of bicyclic adducts, there are two possibilities;
a favored endo adduct, shown for the maleic anhydride cyclopentadiene adduct (Fig 2.3,
A.), as well as an exo product (Fig 2.3, B). This selectivity is governed by the Alder rule,
or the rule o f maximum accumulation o f unsaturation. The comprehensive interpretation
o f this rule is such that when the maximum amount o f unsaturated orbitals interact in the
Preferred

Less Preferred

A
Transition state for
endo product

B

Transition state for
exo product

Figure 2 3 . Transition states for endo vs. exo regioisomers

transition state, the stereospecific isomer corresponding to this transition state will
predominate. To fully interpret the stereo- and regioselectivity o f this reaction, a closer
look into the reaction mechanism is required. The regioselectivity incorporated into the
formation o f the unsymmetrical adducts must also be acknowledged.

17
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The Diels-Alder reaction is an example o f a pericyclic reaction. The conventional
definition o f a pericyclic reaction envelops the idea that the mechanism involves the
reorganization of molecular orbitals within two systems rather than the combination o f
ionic (i.e. carbanions, SN2) or radical species. Pericyclic reactions occur via the
interactions of the highest occupied molecular orbital (HOMO) of one species with the
lowest unoccupied molecular orbital (LUMO) o f another (Fig 2.4).
Figure 2.4 shows generic representations o f the molecular orbitals in a Diels-

dienophile

diene

diene

dienophile

LUMO —
LUMO
HOMO

—

4—

Y

\

LUMO

LUMO

HOMO

HOMO

HOMO

4-

I

X ,

i

.

System in which the diene possesses
electron donating group(s) and the
dienophile posesses electron withdrawing
group(s)

Unperturbed system

Figure 2.4. Frontier orbital interactions in [4+2] cycloaddition reactions
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Alder cycloaddition reaction. In the case o f a cycloaddition reaction, orbitals o f proper
symmetry and energy are uniquely postured for interaction. In the case of Diels-Alder
cycloaddition reactions, it is the interaction of the HOMO o f the 4 k system (the diene)
and the LUMO of the 2ft system (the dienophile). As shown in Figure 2.5, the symmetry
o f the 4ft systems HOMO correlates to the symmetry o f the LUMO 2ft system. The
second factor, the similar energy element, is also uniquely set up for a cycloaddition
reaction. The most similar molecular orbitals, in relation to energy, are the HOMO o f the
diene and the LUMO o f the dienophile. These two factors together make for a favorable
orbital interaction and subsequent reaction.

LUMO

LUMO

HOMO

HOMO

Diene

Dienophile

Figure 2.5. Orbital symmetry o f 2 and 4 ft systems
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It has been shown that in the presence o f electron withdrawing substituents on the
2tcsystem as well as electron donating substituents on the 4tc system, the relative rates of
reactivity increase as shown in Table 2.1 (Carey, 1984). The overall reactivity as well as
the regioselectivity o f the Diels-Alder reaction can be delineated using Figures 2.4,2.5
and 2.6. Figure 2.6 shows the predicted outcome when dienes bear an electron donating
group on either the 1 or 2 position and a single electron withdrawing group is present on
the dienophile. The increased electron density on the a-carbon relative to the donating
group at the 1 position increases the overall energy o f the diene’s HOMO as well as

T able 2.1: Relative Reactivity Toward Cyclopentadiene in the Diels Alder
Reaction*

Dienophile

Relative Rate

Tetracyanoethylene

4.3 X 107

1,1 -Dicyanoethy lene

4.5 X 10s

p-Benzoquinone

5.6 X 104

Maleonitrile

91

Fumaronitrile

81

Dimethyl Fumarate

74

Dimethyl Maleate

0.6

Methyl Acrylate

1.2

Acrylonitrile

1.0

a From second order rate constants in dioxane at 20 °C (Wuest, 1964).
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directing the major amount o f electron density on the a-carbon, thus regioselectively
governing the outcome of the reaction. The increased overall energy of the HOMO in the
2- substituted case remains the same as the 1- substituted case although the
regioselectivity has been reversed. The increased electron density is now on the ^-carbon
relative to the electron donating group thus giving rise to the 1,4 cyclohexenyl adduct.
The aim of this chapter is to assess the reactivity of DOG as a dienophile in the
Diels-Alder reaction. The combination of some well known dienes and DOG will be
examined. Specifically, the reactivity and regiochemical results obtained from the
reaction o f DOG with symmetrical and unsymmetrical dienes will be examined. The

D

D

3,4-disubstituted cyclohexene
Favorable orbital overlap

1,4-disubstituted cyclohexene

Figure 2.6. Representative regioselective outcomes
due to substituent effects

structure o f DOG (2.6 on page 14) contains all the essential elements to be a productive
dienophile in the Diels-Alder reaction. The olefinic portion o f the compound is flanked
21
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by two electron withdrawing groups, which should decrease the energy o f its LUMO
(relative to an unsubstituted olefin) and activate it as a dienophile. Although the two
groups adjacent to the olefin are electron withdrawing, they are not identical and,
therefore, the molecule is not symmetrical and a regioselective reaction is expected. The
keto-ester moiety is more electron withdrawing than is the ester group and thus should
partially govern the regioselectivity o f the reaction with unsymmetrical dienes. Namely,
with 2-methyl-1,3-butadiene, the major regioisomer will should have the methyl group on
the 4 position relative to the ketoester moiety etc.
Solvents are of particular interest in the Diels-Alder reaction. The Diels-Alder
reaction is theorized to progress through an aromatic transition state (Carey, 1984). In
the case o f a pericyclic reaction, the new carbon-carbon bonds are formed by the
combination of 7? molecular orbitals o f the diene and dienophile. In general, this may be
compared to that o f electron delocalization in an aromatic system, therefore, an aromatic
solvent allows the transition state to be more easily reached than a non-aromatic solvent.
Although this rational tends to hold true, it has also been shown that various polar
solvents can be just as effective in the Diels-Alder reaction, although the proposed
interactions differ from that o f an aromatic solvent Carey, 1984).
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n.

Results and Discussion

1. Multigram synthesis o f the key intermediate dimethyl 2-oxoglutaconate (DOG) (2.3)
(for a detailed analysis and spectral data see: Carrigan, 1999.

2-Oxoglutarate (89.4 g) was reacted with thionyl chloride in MeOH to afford
dimethyl 2-oxoglutarate (2.5) in quantitative yield. The resulting diester was treated with

0
SOCI2
c h 3o h m
2 .4 2-oxoglu taric acid

p X

0

2

CH3

Br2

h 3 c o 2c

CH2 CI2

2 .5: dim ethyl 2-oxoglu tarate

O
co 2ch 3
h 3 c o 2c

TEA
Et20

c o 2ch 3
h 3 c o 2c
23 dim ethyl 4 -o x o g lu ta co n a te

2.6: dim ethyl 3-b ro m o -2 oxogiutarate

(D O G )

Figure 2.7: Synthesis o f DOG as described by Corey and Co-Workers

bromine in CH 2CI2 and stirred at reflux to afford the crude dimethyl 3-bromo-2oxoglutarate (2.4) in quantitative yield. In the final step in the preparation o f DOG,
dimethyl 3-bromo-2-oxoglutarate was dehydrohalogenated with triethylamine in diethyl
ether to afford DOG (2 3 , 102.5 g, 97.3% overall) after filtration through a plug o f silica
23
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gel and subsequent recrystallization with ethyl acetate and hexanes. The product DOG
showed physical and spectral details identical to that reported (Carrigan, 1999).

24

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

2. Survey o f DOG as a dienophile in the Diels-Alder cycloaddition reaction

Figures 2.8 - 2.11 show the products of the reactions that have been attempted in
the laboratory. The reaction conditions and percent yields (Table 2.2) reveal the high

c o 2c h 3
c o 2ch 3

2.7 (58 - >95%)

C0 2 CH3

co 2ch3

co2ch3

co2ch3

2.8 (71 - >95%)

2.9 (>95%)

Figure 2.8. Monocyclic Diels-Alder adducts from symmetrical dienes

reactivity and success o f DOG as a dienophile in the Diels-Alder reaction. As is evident
in the table, high temperatures and pressures are not needed for this reaction to proceed.
In the cases where a non-aromatic solvent was used, either the diene was lower boiling
than benzene, or was so reactive that an aromatic solvent was not required. In the case of
the reaction utilizing furan as the diene, increased temperatures were required to
overcome, or break, the aromaticity o f the diene. In utilizing anthracene as the diene,
high temperature was required to solubilize the anthracene.
The trans orientation o f DOG presents additional interesting features in this
reaction. With symmetrical open chain dienes, the adducts obtained will have two newly
25
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Table 2.2. Conditions and yields for Diels-Alder reactions between DOG and select
dienes
Adduct number

Diene

Solvent

Conditions

Percent Yield

2.7
2.7

m-xylene
CH2C12

reflux
rt

58
>95

hexanes

0 °C — reflux

71

benzene

sealed tube
80 °C

88

CH2CI2

reflux

>95

2.10
2.10

Sulfolene
1.3-butadiene
2.3-dimethyl1.3-butadiene
2.3-dimethyl1.3-butadiene
2.3-dimethyl1.3-butadiene
1.4-diphenyl1,3-butadiene
Cyclopentadiene
Cyclopentadiene

2.11

1.3-cyclohexadiene

benzene

2.11

1.3-cyclohexadiene

benzene

2.12

Furan

furan

2.12

Furan

CH2CI2

2.12

Furan

CH2CI2

2.13

2-methylfuran

CH2CI2

2.14

2.5-dimethylfuran

benzene

2.14

2.5-dimethylfuran

CH2CI2

2.14

2.5-dimethylfuran

CH2CI2

2.15

2.3.4.5-tetraphenylcyclopentadienone

benzene

2.16

Anthracene

benzene

2.17

Acridine

benzene

2.18

Phenazine

CH2CI2

2.19

Isoprene
furfural

CH2CI2

2.8
2.8
2.8
2.9

2.20

am ine

>95

CH2CI2
CH2CI2
benzene

rt
0°C
sealed tube
150 °C
reflux
sealed tube
150 °C
reflux
rt
AlClj
reflux
sealed tube
110°C
reflux
rt
A1CU
sealed tube
150 °C
sealed tube
150 °C
sealed tube
150 °C
sealed tube
150 °C
reflux

CH2CI2

“N/R = no reaction
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90
86
83
58
28
8

67
>95
N/Ra
N/Ra
N/Ra
N/Ra
67
N/Ra
N/Ra
> 95
84

A

A

c o 2ch 3

c o 2ch 3

0

h 3^ S <

c o 2c h 3

^

C

Q

C02CH3

0< ^

c o 2ch 3

2.12 (8 -67%)

2.11 (58 - 83%)

2.10 (86 • 90%)

^ a c o 2c h 3

c o 2c h 3

Cq 2CH3

h35 ^ Y

c o 2ch 3

2.13 (>95%)

co 2ch 3

2.14 (N/R)

2.15 (N/R)

Figure 2.9. Bicyclic Diels-Alder adducts

2.16 (67%)

2.17 (N/R)

co 2c h 3

2.18 (N/R)

Figure 2.10. Diels-Alder adducts from extended aromatic dienes
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formed chiral centers. The interesting feature of this system is that only two
stereoisomeric products are obtained. Since the dienophile is the trans isomer, the

O

o
T

C 0 2 CH3

CO2CH3

'n

°= < CF„
2.19 (>95%)

C 0 2 CH3

2.20 (84%)
O

CO2 CH3

H3 i

C0 2 CH3

2.13 (>95%)

Figure 2.11. Diels-Alder adducts derived from unsymmetrical dienes

cycloaddition adducts will be trans across the 4-5 bond o f the cyclohexenyl products,
therefore, producing a mixture o f only two enandomers. For the adducts 2.7 and 2.8 the
lH NMR spectra indicate the trans ring junction by affording a doublet of triplets at 2.81
and 2.95 ppm, respectively with coupling constant values o f 11.1 and 14.6 Hz,
respectfully. In the case o f the diphenyl substituted cyclohexenyl adduct (2.9), there will
be four total chiral centers, but the product mixture will contain only four stereoisomers.
In the formation o f the adduct, the phenyl rings at the 3 and 6 position o f the cyclohexene
will be cis relative to one another, in turn, limiting the number o f stereoisomers obtained.
With this limitation, as well as the trans orientation about the 4-5 bond, indicated by the
28
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coupling constant o f the triplet corresponding to the proton alpha to the ester of 11.4 Hz,
the number o f isomers is well short of that which would be obtained if a nonstereospecific reaction sequence was used (i.e. 2" = 24 = 16).
Table 2.2 also reveals that the relative rates o f reaction for furan, 2-methylfuran
and 2, 5-dimethylfuran differ considerably. The interaction o f the dienes with DOG in
the transition state is highly dependent on the energy o f the HOMO o f the dienes. The
HOMO energies (calculated using PC Spartan Pro 1.0.S, Irvine CA) for the dienes are
given in Table 2.6. The consistent feature o f the calculations is that the respective
HOMO energies o f furan, 2-methylfuran and 2, 5-dimethylfuran increase with the
addition of electron donating substituents and this, in turn, should increase the reactivity
with DOG, although the reactions utilizing furan and 2, 5-dimethylfuran as the diene are
extremely more sluggish than that with 2-methylfuran. This is most likely due to the fact
that the HOMO o f furan is too low in energy to interact constructively with the LUMO of
DOG and that the HOMO o f 2, 3-dimethylfuran may have been increased so much that it
has surpassed the level o f energy that is required to interact favorably with DOG in the
Diels-Alder reaction. Another piece o f evidence that adds confidence to this hypothesis
is that when a catalytic amount o f AlCb was added to the reaction mixture o f furan and
DOG, the reaction was complete in less than five minutes and the yield was increased to
68% (not optimized). This supports the theory that the LUMO o f DOG is too high to
interact with furan under non-catalytic conditions but once the catalyst is added, the
coordination of the ketone o f DOG with the aluminum atom leads to a decrease in DOG’s
LUMO enough to interact considerably with the HOMO o f furan. Also, when a catalytic
amount o f AICI3 was added to the reaction mixture o f 2, 5-dimethylfuran and DOG, no
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increase in percent yield was achieved and more by-products were detected by thin layer
chromatographic (TLC) analysis. This adds further evidence in support of the

Table 2.3. Energies and yield o f substituted furan Diels-Alder adducts

Diene

HOMO Energy
(eV)a

Percent Yield

Percent Yield
with AICI3

2, 5-dimethylfuran
2-methylfuran
Furan

-8.755
-9.015
-9.312

N/Rb
>95
8

N/Rb
N/Ac
68

aa as calculated
i _.i j with twVo
■' P
« ro,b
bvr
PC Spartan
N/R = no reaction,
c N/A = not assessed due to the high reactivity in the absence o f catalyst

interpretation that the HOMO o f 2, 5-dimethylfuran has risen above that o f DOG and a
productive HOMO / LUMO interaction can not be achieved.
The low reactivity o f 2 , 3 , 4 , 5-tetraphenylcyclopentadienone may be due to a
collection o f factors including the crowded nature about the diene due to the four
aromatic groups, the slight electron withdrawing nature o f the phenyl groups as well as
the electron withdrawing nature of the ketone moiety (Figure 2.12).
The aromatic molecules anthracene, phenazine and acridine also show much
different reactivities in the Diels-Alder reaction with DOG. As is shown in Table 2.5,
anthracene was able to undergo the Diels-Alder reaction with DOG in modest yield but
the reaction with phenazine and acridine resulted in no reaction. The incorporation o f the
nitrogen atoms in the ring may slow the reaction by having the aromatic nature removed
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Figure 2.12. Structure of 2, 3,4, 5-tetraphenylcyclopentadienone
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at the end o f the reaction. Although the two rings next to the nitrogens are aromatic, the
activation energy needed to achieve the transition state may be too high with phenazine
and acridine.
Since the overall goal o f the project was the synthesis of structurally constrained
amino acid analogues, the survey o f the regioselective nature o f DOG in the Diels-Alder
reaction with DOG was examined only briefly. Three dienes were used: isoprene, 2methylfuran and N-trifluoroacetyl furfuralamine (Figure 2.11). With isoprene, the
reaction mixture produced two regioisomers collectively with excellent yield and a
regioisomer ratio o f 66:34 as determined by integration o f the ester a-proton doublet of
triplets in the lH NMR (Figure 2.13).
The ketone group appears to control the regioselectivity of the reaction as
evidenced by the 'H NMR chemical shifts and coupling patterns o f the DOG adducts
with furan, 2 -methylfuran and N-trifluoroacetylfurfural amine. Figure 2.14 shows a stack
o f the three *H NMR spectra o f the resulting adducts. As is seen in the spectra o f the
furan-DOG adduct there is a broad doublet o f doublets at 7.34 ppm assigned to the
bridgehead proton (Ha) adjacent to the proton alpha to the ketone functionality. The
spectra o f the 2-methylfuran-DOG adduct contains no resonance between 7 and

8

ppm

but there is an additional singlet appearing at 2.18 ppm corresponding to the newly
introduced bridgehead methyl group. In the spectra for the Ntrifluoroacetylftirfuralamine-DOG adduct, there is a broad triplet at 7.48 ppm
corresponding to the amide hydrogen and a new resonance at 4.36 ppm corresponding to
the methylene carbon alpha to the amide nitrogen. These data suggest that the
regiochemistry o f the reaction is consistent and controlled by the carbonyl groups such
32
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Figure 2.13. 'H NMR of the regioisomer mixture obtained from the Diels-Alder reaction between DOG and isoprene

4
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Figure 2.14. 'H NMR comparison of N-trifluoroacetylfurftiralamine (2.20), 2-methylfiiran (2.13) and furan (2.10)-DOG adducts.

COjCH*

that the donor group in the diene aligns with the ketoester moiety (Figure 2.14).
Although the regiochemistry o f this reaction was only slightly researched, the potential to
synthesize regiochemically specific keto-esters in route to the corresponding glutamate
analogues may be of tremendous benefit in the future.
It was shown that DOG is a highly reactive dienophile in the Diels-Alder reaction.
The reaction was successful with the dienes sulfolene (1, 3-butadiene), 2, 3-dimethyl-1,
3-butadiene, 1,4-diphenyl-1,3-butadiene, cyclohexadiene, cyclopentadiene, furan, 2methylfuran, 2 , 3 , 4 , 5-tetraphenylcyclopentadienone, anthracene, isoprene and Ntrifluoroacetyl furfuralamine. It was also shown that the dienes acridine, phenazine and
2, 5-dimethylfuran were not of sufficient reactivity to partner with DOG in the DielsAlder reaction.
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3. Ketone to amine transformation: Formal reductive amination

The justification for the use o f DOG as a dienophile in the Diels-Alder reaction
was predicted on the fact that the keto-ester cyclic products are potential starting
materials for the synthesis o f 3 ,4-conformationally-restricted L-glutamate analogues.
The key chemical transformation to access the conformationally constrained glutamate
analogues is the conversion o f the a-keto ester moiety into an a-amino ester. The
reductive amination o f ketones is well documented (for a review see, Hutchins, 1979).
One common route used to convert a ketone into an amine is reduction o f an imine
formed by the condensation of a ketone with a 1° amine (Figure 2.15) including: a)
hydrogenation over a nickel (Norton, 1954), b) platinum (Freifelder, 1966) or c)
palladium catalyst (Eleveld, 1986), d) NaBFL (Hutchins, 1983, and references therein)
and one o f the most mild and selective, to date, e) NaCNBH 3 (for a good review see,
Lane, 1975). The reductive amination success relies on high conversion o f the carbonyl
and the amine to the imine and many different procedures have been adapted to increase
the formation o f the imine including the use of: a) dehydrating agents such as molecular
sieves (Bonnett, 1965), b) removal of water under azeotropic conditions using benzene or
toluene (Wrobel, 1981) c) acid catalysis utilizing acetic acid (Hutchins, 1979) and d)
TiCL is used as a Lewis acid catalyst as well as the dehydrating agent (Weingarten,
1967).
A vast number o f different conditions were employed in the laboratory to effect
the reductive amination o f the structurally constrained keto esters via an imine
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intermediate, but, the structures do not appear to be good substrates for this reaction.
There are a number o f reasons that the reaction may fail. The steric constraints

Solvent—H
—Solvent
: oh

Of 2
Ri^-R

■71-R2

Dehydration

R1 fj~R2

NHR*

•v*

(r

Ri^Rz

Intramolecular
proton transfer

:nh 2r ‘
: oh
Ri- | ~ R 2
NHR'

M

Intramolecular
proton transfer

nn' rIntermediate
imine

Figure 2.15. Formation of the imine intermediate in route to reductive amination

imposed about the ketone moiety make the region too crowded for an effective imine
formation. This seems to be highly unlikely due to the fact that the ketone can be
converted to the corresponding oxime and dimethylhydrazone, which proceed by a
similar mechanism (discussed later). Another factor that may effect the imine formation
is that the ketone may readily enolize in the presence o f certain acid catalysts that prevent
the nucleophilic addition of the amine to the ketone functionality but, once again, this
argument may be contradicted, in part, by the relative ease of formation o f the oxime and
dimethylhydrazone products, hi the case where ammonia and primary amines were used
as the initial nucleophile, there is a large opportunity for amide formation with the ester
functionalities o f the starting materials. Although this is a distinct possibility, it was not
researched exhaustively due to the fact that, although the problem is an interesting one in
37
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mechanistic organic chemistry, the product amino acids were highly desired and the
search for a procedure to produce them in good yields predominated over a mechanistic
investigation. Table 2.4 summarizes some of the conditions we explored unsuccessfully
in route to the imine.

Table 2.4. Conditions employed for chemical reductive amination

Starting Material

Amine Eq.

Reducing agent

Solvent

Conditions

HC1 (cat.)
rt

dimethyl 2-oxoglutarate

NH JJr

NaBHsCN

CH3OH

dimethyl 2-oxoglutarate

benzylamine

NaBHaCN

CH 3OH HOAc (cat.)
rt

dimethyl 2-oxoglutarate

benzylamine

NaBHsCN

CH3OH HOAc (cat.)
rt
4A sieves

dimethyl 2-oxoglutarate

benzylamine

NaBHsCN

CH3OH HOAc (cat.)
reflux

2-oxoglutarate

benzylamine

NaBHsCN

CH3OH HOAc (cat.)
reflux

The ketoxime o f compound 2.8 (Figure 2.16) was synthesized by the addition of
ammonium acetate trihydrate to a solution o f 2.8 and hydroxylamine hydrochloride in
ethanol. The resultant ketoxime was isolated as a white solid in 42 % yield after
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recrystallization from ethanol As mentioned above, it has
n »OH
^ j^ ^ ^ ^ C

0 2 CH3

C0 2CH3
Figure 2.16. Ketoxime
(2 .2 1 ) o f compound 2 . 8

been shown that ketoximes can be reduced to their
corresponding amines by hydrogen and Raney nickel (Norton,
1954). This reaction was attempted in the lab, but was
initially unsuccessful and not highly researched according to
6

the arguments stated above as well as the fact that there is a
high potential for the reduction o f the olefin moiety in the molecule, which is a necessary
component o f our final amino acid molecules to impose the conformational restriction
about the 1, 2 bond. In addition, the reduction o f the olefin double bond would introduce
two new centers o f chirality which, even though the reduction is stereoselective, will
double the number of product stereoisomers and render product isolation more difficult,
therefore, a more selective reagent was sought.
Serckx-Poncin and co-workers (1982) have shown that the nitrogen-nitrogen bond
of a hydrazine can be broken using zinc in acetic acid. With this in mind, it was
postulated that the double bond of a hydrazone could also be reduced under these
conditions, therefore, introducing a new hydrazine bond which would be subsequently
reductively cleaved under the reaction conditions to afford the desired amino diesters.
With this in mind, we set out to synthesize the N, N-dimethylhydrazone derivatives o f the
keto diester adducts previously obtained in the Diels-Alder reaction and survey their
potential as substrates for the reductive cleavage reaction in the preparation o f the
corresponding conformationally restricted analogues o f glutamate (figure 2.17). The
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o
X
X

CH2C12
x o 2CH3

C0 2CH3

x

(CH3)2NNH2

c o 2c h 3

HOAc
X

c o 2c h 3

Figure 2.17. Synthesis o f N, N-dimethylhydrazones o f the Diels-Alder adducts. The
identity of X is described in table 2.2

hydrazones were accessed by the condensation o f N, N-dimethylhydrazine with the keto
diester adducts, catalyzed by acetic acid in dichloromethane, ranging from 79-91 percent
yield. One very important factor in this reaction is its convenience and ease o f execution.
The dichloromethane solvent and the hydrazine reagent are both very low boiling and
thus readily removed in vacuo. The acetic acid catalyst is readily removed by an aqueous
workup and the hydrazone products are readily obtained via flash chromatography (see
the Experimental section). Four hydrazones were successfully synthesized from the
ketone precursors (Figure 2.18).
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c o 2c h 3

h

r

3
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c o 2c h 3
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C0 2CH3
ch3

2.24

2.25

Figure 2.18. Hydrazone products from select Diels-Alder adducts

Once the hydrazones were synthesized, their ability as substrates was assessed in
a tandem reduction, reductive cleavage reaction. It was brought to our attention that the
tandem reduction, reductive cleavage reaction has been accomplished with the use o f
sodium hydrosulfate under aqueous conditions (DeGraw, personal communication).
With this information, as well as the evidence that under the conditions using zinc and
acetic acid, double bonds are readily reduced (Serckx-Poncin, 1983), conditions to
perform the sequence with sodium hydrosulfate were first considered. The reader is
advised that sodium hydrosulfate may also be called sodium thiosulfite.
It is essential that a solvent capable o f dissolving the sodium hydrosulfate to a
substantial amount that it can interact with the hydrazone is used. It was determined that
a mixture of water and methanol ( 1 : 1 ) under reflux was a favorable set o f conditions.
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Figure 2.19 shows the reagents and products o f the reactions o f compounds 2.22 - 2.24
with sodium hydrosulfate in water-methanol ( 1 : 1 ).
The products arising from the reduction o f the monocyclic cases are lactam esters
and lactam acids 2.26 - 2.29, resulting from initial formation o f the desired amine
followed by cyclization and hydrolysis. In the bicyclic cases, the products 2.30 - 2.31 are
obtained as amino diesters. It is assumed that the lactams are not formed in the bicyclic
cases due to the extra rigidity o f the molecules exerted by the bridging methylene groups.
Due to the nature o f these compounds to form lactams, the number of
glutamate analogues has increased due to an intermediate structure showing activity in
biological preparations.
For compounds 2.24 and 2.25, the intermediate amino esters (2.30 and 2.31) were
isolated by a simple aqueous extraction, identified by electrospray mass spectrometry
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Figure 2.19. Sodium hydrosulfate reduction o f hydrazones
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Figure 2.20. Saponification to afford the target amino acids

(ESI-MS) and used directly in the next reaction without further purification or
characterization.
To access the amino acid analogues, the lactam acids, lactam esters or amino
esters were subsequently saponified with sodium hydroxide (Figure 2.20) and purified by
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ion exchange chromatography to afford the amino acid hydrochorides 2.32, 2.33, 2.34
and 2.35 in 58, 85, >95 and 76 % yield, respectively. These newly formed,
conformationally restricted glutamate analogues were tested as inhibitors o f the sodium
dependent excitatory amino acid transporters EAAT2 and EAAT3, the chloride
dependent glial cystine/glutamate exchanger system Xc\ and the glutamate vesicular
transport system (VGLUT) (for details, see Chapter 4).
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4. Synthesis o f l-dimethylamino-3-methoxyoxalyl-l,2,3,4-tetrahydro-pyridine-2carboxylic acid methyl esters. Reaction o f DOG with azadienes (a, fi-unsaturated N, Ndimethylhydrazones).

Once it was determined that DOG was a reactive dienophile in the Diels-Alder
reaction and the subsequent adducts were starting materials for the synthesis of
conformationally restricted glutamates with biological activity, it was in our interest to
synthesize a number o f amino acid derivatives that will mimic glutamate. It has been
shown that a , (3 -unsaturated hydrazones derived from a , (3-unsaturated aldehydes readily
undergo the Diels-Alder reaction with electrophilic dienophiles. Data has supported the
theory that the mechanism o f the reaction is not truly a 4 + 2 cycloaddition reaction, but
an initial 1 ,4 addition o f the hydrazone with the double bond of the dienophile, followed
by an intramolecular nucleophilic ring closure of the intermediate enolate onto the newly
formed iminium ion (Figure 2.21).

o '

Cjj^COzCHa
h 3c o 2c

c o 2c h 3

h 3c o 2c .

X

c o 2c h 3
>2c h 3

Figure 2.21. Proposed mechanism and reaction outcome between DOG and a , (3
unsaturated N, N-dimethylhydrazones

46

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

The mechanism o f this reaction has been substantiated by a number of methods.
Serckx-Poncin and co workers (1983) have shown when the N, N-dimethylhydrazone
derived from methacrolein (Compound 2.36) undergoes reaction with electrophilic
dienophiles, specifically, acrylonitrile and methyl vinylketone, the regiochemistry o f the
reaction is inverse to that which is expected in a typical, molecular orbital driven, DielsAlder cycloaddition reaction (Figure 2.22). Further evidence that the mechanism is
following the path described in Figure 2.21 is that when the cycloaddition is performed
between the N, N-dimethylhydrazone o f acrolein with dimethyl fumarate and dimethyl
maleate, the resulting cycloadducts have the same trans configuration about the 5-6 bond

Figure 2.22. Regiochemical outcomes of the reaction of methacrolein N, Ndimethylhydrazone with acrylonitrile and methylvinylketone (Serckx-Poncin, 1983)

as determined by the coupling constants o f the vicinal protons on carbons C 5 and C6 (J =
8

Hz). The authors further confirmed the trans stereochemistry by the synthesis o f the cis

isomer and subsequent analysis o f the coupling constants o f the vicinal vicinal protons on
carbons C5 and C6 (./= 4 Hz) (Serckx-Poncin, 1983). The trans orientation could only
have resulted in a stepwise mechanism with dimethyl fumarate as an electrophile.
With this data in hand, we set out to perform the cycloaddition reaction o f the
hydrazones o f methacrolein and acrolein as an exploratory but direct route to a new class
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o f structurally constrained glutamate analogues, namely, l-dimethylamino-3methoxyoxalyl-l,2,3,4-tetrahydro-pyridine-2-carboxylic acid methyl esters. Figure 2.23
shows the two model adducts (2.36 and 2.37) formed by the reaction between the N, Ndimethylhydrazones of acrolein and methacrolein and DOG. The regiochemistry was
determined to be consistent with the structure depicted in Figure 2.23 by utilizing the
knowledge of the reaction mechanism (figure 2.21) for the 1,4 addition-cyclization as
well as interpretation of the ‘H NMR o f the adducts. Adducts 2.36 and 2.37 both have a

N A c o 2c h 3

2.36

X

C0 2CH3
)2 c h 3

2.37

Figure 2.23. Adducts o f the reaction between the N, N-dimethylhydrazones o f acrolein
and methacrolein and DOG

triplet of doublets appearing at 3.41 and 3.21 ppm, respectively. This indicates that the
proton giving rise to this resonance is alpha to the ketone, for example, in compound 2.7
the chemical shift for the proton alpha to the ketone is 3.45 ppm while the chemical shift
for the proton alpha to the ester resonates at 2.81 ppm and in the adduct 2 . 8 the chemical
shift o f the proton alpha to the ketone is 3.56 ppm where the proton alpha to the ester
resonates at 2.95 ppm.
The adducts formed in this sequence provide the intermediate materials for the
synthesis o f a new class o f structurally constrained glutamates which incorporate the
nitrogen o f the amino acid within the ring. Besides having the conformation o f glutamate
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locked about the 2-3 bond o f the glutamate backbone, there is also a new feature
introduced into the chemical structure, a ketone at the 4 position. This additional feature
in the glutamate backbone may serve to further elucidate the structural requirements for
analogues to bind constructively at glutamate transporters. The introduction o f the
ketone group in the intermediates also adds a functional group that can be further
manipulated numerous ways to incorporate many new functional groups into the amino
acid structure (see Chapter S).
To access the final amino acid analogue structure requires the reductive cleavage
o f the hydrazine bond. This reaction has been accomplished with zinc in acetic acid,
although the olefin moiety was also reduced. Although this potentially detracts from the
structural rigidity of

X

C 02CH3
)2CH3

Zn
HOAc

2.36

X

C02CH3
>2c h 3

2.38

Figure 2.24. Reduction o f hydrazine and olefin with zinc in acetic acid

the analogues, there is one positive note. In the case o f the acrolein adduct, if the tandem
reduction-reductive cleavage were to occur without reduction of the olefin, the new
product will be an enamine, which has a high potential o f ring opening to form the
aldehyde containing molecule 2-amino-4-oxo-3-(2-oxo-ethyl)-pentanedioic acid dimethyl
ester. This molecule itself is a new analogue o f glutamate with potential for further
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manipulation, but it’s synthesis, characterization and manipulation is only theoretical to
date.
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5. Investigations into the synthesis o f 4-oxoglutamate

Once it was determined that the Diels-Alder reaction with a , [3-unsaturated
hydrazones was a success and had potential for accessing 4-oxoglutamate analogues, the
synthesis of the most simple 4-oxoglutamate (Compound 2.40, Figure 2.2S) was
undertaken. Although the synthesis as shown in figure 2.25 is logical, the actual

H3C02C

c o 2c h 3

H3C0 2Cv ^ ' n s^.C0 2CH3

ch 2ci2

2.39

2. NaOH

NH2 O
2.40

Figure 2.2S. Proposed synthesis o f 4-oxoglutamate

sequence o f events which take place are outlined in Figure 2.26. Upon initial 1,4
addition o f benzylamine to DOG, the subsequent amino compound readily cyclizes to
form the substituted pyrrolidine (2.41) which subsequently reacts with a second
equivalent o f amine to form the pyrrolidinoenamine (2.42). This molecule is easily
hydrolyzed back to the pyrrolidine under aqueous conditions. When only 1 equivalent of
amine was used, the yield o f product, 1-benzyl-4-benzylamino-5-oxo-2,5-dihydro-1H51

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

pyrrole-2-carboxylic acid methyl ester (2.41), was isolated in less than 50 % yield. If two
equivalents o f amine were used, the yield was increased substantially. This indicates that
the formation o f the enamine is equally or more rapid as the initial 1 , 4 addition,

NH

H3 CO2 C

A

H3co 2cr xn h o c h 3

.

OCH3
'

\

2.39

DOG

NH
H+

H20

2.42

2.41

2.41
Figure 2.26. 1,4 Addition-cyclization-enamine formation o f benzylamine with DOG
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therefore, to access the pyrrolidine 2.41, it is necessary to use two equivalents o f amine
and subsequently hydrolize the enamine product (2.42) back to the intermediate target
molecule, 1-benzyl-4,S-dioxo-pyrrolidine-2-carboxylic acid methyl ester (2.41).
Preliminary investigations into the hydrogenolysis of compound (2.41) have been
attempted, and reduction of the ketone is evident in the 'H NMR and ESI-MS of the
crude reaction mixture. Future manipulations o f compound (2.41) will be discussed in
Chapter 5.
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6. Synthesis o f structurally constrained 2-oxoglutarate analogues: potential substrates o f
dehydrogenases and aminotransferases

One o f the initial goals o f the project was to synthesize the conformationally
constrained glutamate analogues in a stereoselective manner utilizing an enzymatic
transformation to convert the keto ester to an amino acid. For this route to be researched,
it was necessary to synthesize the substrate 2-oxoglutarates. A brief panel o f substrates
(2.43, 2.44,2.45, 2.46 and 2.47) was synthesized by the saponification of the Diels-Alder
adducts 2.7, 2.8,2.10 and 2.11 (Figure 2.25). A solution o f the keto ester in MeOH was
saponified with an excess o f aqueous sodium hydroxide (NaOH). The resultant
ketocarboxylate salts were protonated with hydrochloric acid, extracted with diethyl
ether, dried over anhydrous magnesium sulfate and the crude oils were obtained after
evaporation o f the solvent. Further purification o f the keto diacids by ion exchange or
traditional chromatography (below) was very difficult; therefore, the crude keto diacids
were used as substrates in the transamination reaction (see Chapter 3).
Purification of the ketoacids was attempted by a number o f methods. First, the
acids were subjected to anion exchange chromatography. The aqueous solutions o f the
ketoacid sodium salts were prepared by the addition o f NaOH to a vigorously stirred
slurry/solution of ketoacid in water until all o f the oil was dissolved (ca. pH 8 ). The
solution was added to a cation exchange column (BioRad, AG 1-X2,, 20 g resin / gram
ketoacid), and washed with water to remove any inorganic ions. It was attempted to elute
the keto acids with an increasing gradient o f aqueous acetic acid, but the acids were only
sparingly soluble in aqueous solution and became virtually inseparable from the resin.
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Figure 2.27. Saponification o f keto ester Diels-Alder adducts

55

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Attempts to extract the keto acids from the resin with hydrochloric acid and methanol or
as their pyridinium salts with aqueous pyridine also failed.
It was also attempted to form a salt that may be isolated by crystallization. In an
attempt to form an insoluble barium salt a solution/slurry o f keto acid in water was
treated with saturated Ba(OH)2 until pH > 10. The resultant solution was let stand at rt
for up to thirty days with no appreciable precipitation.
In an attempt to form the salt with the organic base N, N-dicyclohexylamine, a
solution o f keto diacid in diethyl ether was treated with the amine and the resultant
solution was allowed to stand at rt °C in excess o f 60 days with no appreciable
precipitation o f the salt.
It was then attempted to purify the keto diacids by high performance liquid
chromatography (HPLC). Because the keto diacids have a poor chromophore, it was
very difficult to detect them with a UV/visible detector coupled to the HPLC, although it
was attempted. The keto diacids were injected into the HPLC eluting with various ratios
o f MeOH in water (0-50 %) containing 0.08 % trifluoroacetic acid (TFA). Conditions for
the preparative purification o f the keto diacids were not optimized due to the fact that the
use o f TFA in the mobile phase spawned a new idea for the isolation o f the keto diacids,
the use o f TFA as the proton source in the isolation o f the keto diacids after
saponification.
It was attempted to precipitate the previously synthesized keto diacids by the
neutralization o f their sodium salts with TFA in water. This method was unsuccessful,
however, it lead to the discovery that the keto diacids could be obtained as brown solids
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after saponification of the keto diesters with 2.1 equivalents o f NaOH, evaporation o f the
solvent, reconstitution in a minimum amount of water and subsequent protonation with
dilute TFA.
Once the initial crude keto diacids were obtained, it was necessary to choose an
enzyme capable o f converting the ketone moiety of our keto diacids into an amine group.
Upon discussion with Dr. Richard Bridges about which enzyme would be the most
logical starting point, we contacted Dr. Arthur Cooper o f the Weill Medical College o f
Cornell University (an expert in the field o f aminotransferases and dehydrogenases). A
collaboration was established with Dr. Cooper in which he would preliminarily survey
our keto diacids as substrates and/or inhibitors o f a panel of aminotransferases,
dehydrogenases and dehydrogenase complexes (for experimental details, see Chapter 3).
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7. Synthesis o f phosphono analogues o f 2-oxoglutarate, 2-oxoisocaproate, 2oxoisovalerate and 2-oxo-3-methylvalerate

The collaboration with Dr. Cooper (section 2.6)initiated a research plan to investigate the
synthesis o f a number of phosphonate analogues o f 2 -oxoglutarate in the search for a
potent and selective inhibitor o f the 2 -oxoglutarate dehydrogenase complex as a model
for neurodegenerative diseases (for an overview of this subject, see: Brown, 2000;
Cooper, 1996, 1998). Compounds 2.48 - 2.50 (Figure 2.28) and 2.51 and 2.52 (Figure
2.29) were identified as targets and were synthesized using a modification o f previously

_
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Figure 2.28: Synthesis o f phosphonate analogues o f 2-oxoglutarate

published work (Khomutov, 1978). Compound 2.48 is obtained via a modified Arbuzov
reaction between ethyl succinylchloride and triethyl phosphite. Compound 2.49 is
obtained via the dealkylation o f the phosphonate esters with bromotrimethylsilane
followed by treatment of 2.49 with 3 equivalents of NaOH in water to afford the trisodio
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salt 2.50. Compound 2.51 was synthesized from triester 2.48 by monodealkylation with
sodium iodide (Nal) in refluxing acetone. The disodium salt 2.52 was synthesized by the

O
IT pCH 2 CH3
P"OCH 2 CH3
O

CH3 CH2 0 2C

Nal
acetone

O
¥ ,0Na
^"OCH 2 CH3
O

^
CH3 CH2 0 2C

2.48

2.51

NaOH

j?
Na02C

pN a
P^OCH2 CH3
O

2.52

Figure 2.29: Synthesis o f phosphono analogues o f 2-oxoglutarate

saponification of the carboxylate ester o f compound 2.51 with NaOH in water. All o f the
products gave satisfactory 'H NMR, l3C NMR and ESI-MS properties (see Experimental
Section).
The molecules described above are phosphono analogues o f 2-oxoglutarate,
which is a substrate for the enzyme complex o f 2-oxoglutarate dehydrogenase. The
reduced capacity o f this enzyme complex is implicated in neurodegenerative diseases.
The selective inhibition o f this complex with a synthetic molecule will decrease its
activity and mimic the disease state which can then be studied. The biological evaluation
o f these compounds to inhibit 2 -oxoglutarate dehydrogenase in vitro and in vivo is being
done by collaborators Dr. Arthur J. L. Cooper and Dr. Gary E. Gibson at the Weill
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Medical College o f Cornell University. The results are pending at the time o f this thesis
preparation.
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III. Experimental

Unless otherwise noted, reactions were run in flame-dried apparatus under argon
atmosphere. Anhydrous reagent grade solvents (methylene chloride, CH 2CI2 :
dimethoxyethane, DME: dimethyl formamide (DMF): tetrahydrofiiran (THF)), toluene,
methanol (MeOH), triethylamine (TEA), were purchased from Aldrich Chemical Co.
Melting points were determined on a Mel-Temp n metal block apparatus and are
uncorrected.

Analytical thin-layer chromatography (TLC) was performed on silica gel

(Whatman) aluminum-backed plates. Flash chromatography was performed with silica
gel. Compounds were detected using UV absorption at 254 nm and/or stained with
ninhydrin or I2 (iodine). lH NMR (400 MHz), 13C NMR (100 MHz) an d 3lP (161 MHz)
spectra were recorded with a Varian 400 MHz Unity Plus spectrometer. Chemical shifts
are reported in parts per million (ppm, 5) using residual solvent signals as internal
standards. High resolution mass spectra (HRMS) were obtained from the University o f
Montana Mass Spectrometry facility with a Micromass LCT HRMS. Elemental analyses
for C, H, and N were performed by Midwest Microlab, Indianapolis, IN. For most
compounds described in this section, analytical (HRMS or elemental analysis) data are
presented. For those compounds devoid o f this data it is because at the time o f synthesis
either the spectrometer was dysfunctional or the amount o f material obtained was
insignificant for an elemental analysis.
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2.3

2.7

Methyl 6-methoxyoxalyl-cyclohex-3-eiiecarboxylate (2.7)

A solution o f DOG (1.19 g, 6.89 mmol) and butadiene sulfone, (8.41 g, 68.90 mmol) in
m-xylene (20 mL) was heated to reflux and stirred for 6 h. The solution was allowed to
cool to rt and the solvent was removed in vacuo. The resultant brown oil was
chromatographed (S i02, 25% EtOAc : hexanes) to afford the product 2.7 (1.17 g, 58.8%)
as a gold oil:

lH NMR (CDCl3, 400 MHz):

8

5.55 (t, J - 1.9 Hz, 2 H), 3.72 (s, 3 H), 3.48 (s, 3

H), 3.45 (td ,y = 5.7, 11.1 Hz, 1 H), 2.81 ( t d ,/= 5.7 Hz, 11.1 Hz, 1 H), 2.40-2.25 (m,
2H), 2.06-1.85 (m, 2 H);
l3C NMR (CDCI3, 100 MHz):

8

196.8, 175.3, 161.5, 125.3, 125.0, 52.8, 52.0,

43.0,41.4,27.5 (2 C);
IR (liquid cell, CDC13):3156, 1727, 1438, 1302, 1267, 1232, 1200, 1179, 1081

Anal. Calcd for C nH l40 5: C, 58.40; H, 6.24. Found: C, 58.44; H, 6.25;
HRMS Calcd for C u H lsQs 227.0919. Found: 227.0925 (M+H)+.
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2.8

Methyl 6-methoxyoxalyl-3,4-dimethyl-cyclohex-3-enecarboxyate (2.8)

A. To a solution o f DOG (9.02 g, 51.85 mmol) in hexanes (30 mL) was added 2,3dimethyl-1,3-butadiene (11.73 mL, 103.7 mmol) and the solution was heated slowly to
reflux until TLC indicated consumption o f starting material. The solvent was removed in
vacuo and the resultant brown oil was chromatographed (S1O 2, 25% EtOAc : hexanes) to
afford the product 2.8 (9.39 g, 70.7%) as a gold oil:

B. To a solution o f DOG (1.14 g,

6 .6

mmol) in CH 2CI2 (30 mL) was added 2,3-dimethyl-

1,3-butadiene (3.97 mL, 33.1 mmol) and the solution was heated to reflux and stirred for
5 min. The solvent was removed in vacuo and the resultant brown oil was
chromatographed (S i02,25% EtO Ac: hexanes) to afford the product 2.8 (1.66 g, 98.1%)
as a gold oil:

C. To a sealable pressure tube was added DOG (1.14 g, 6.61 mmol), 2,3-dimethyl-1,3butadiene (1.49 mL, 13.21 mmol) and benzene (5 mL). The solution was heated to 80 0
C and stirred for 2 h. The solvent was removed in vacuo and the resultant brown oil was
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chromatographed (SiCh, 25% EtOAc : hexanes) to afford the product 2.8 (1.49 g, 88.3%)
as a gold oil:
lH NMR (CDCI3, 400 MHz): 5 3.87 (s, 3 H), 3.63-3.56 (m, 4 H), 2.95 (td, J= 5.7,
14.6 Hz, I H); 2.37-2.24 (m, 2 H); 2.17-1.98 (m, 2 H); 1.53 (s, broad, 6 H);
13C NMR (CDCI3, 100 MHz): 5 197.5, 175.9, 162.0, 124.8, 124.5, 53.3, 52.4,
44.4,42.6,34.1 (2 C), 18.7 (2 C);
IR (liquid cell, CDC13) 3155, 2998,2954,2917,2844, 1722, 1438 cm '1;
A n a l. C a lc d f o r C i 3H ,8 0 5:

C, 61.41; H , 7.13. F o u n d : C, 61.29; H , 7.13.
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o
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2.9

Methyl 6-methoxyoxalyl-2,5-diphenyl-cyclohex-3-enecarboxylate (2.9)

To a solution o f DOG (0.708 g, 4.07 mmol) in benzene (10 mL) was added 1,4-diphenyl1,3-butadiene (1.68 g, 8.14 mmol) and the resulting solution was heated to reflux and
stirred for 12 h. The solvent was removed in vacuo and the residue was chromatographed
(S i02. 25% EtOAc : hexanes) to afford the product 2.9 (1.20 g, 77.4%) as an off white
solid:
mp 109-113 °C
'H NMR (CDC13, 400 MHz): 5 7.39-7.13 (m, 10 H), 5.98-5.88 (m, 2 H), 4.494.46 (br m, 1 H), 4.30 (dd, J = 11.4,6.2 Hz, 1 H), .3.87 (s, 6 H), 3.64-3.61 (m, 1 H), 3.33
(s, 6 H), 3.02 (t, J = 11.4 Hz, 1 H);
l3C NMR (CDCh, 100 MHz):

6

193.2, 175.1, 160.4, 141.9, 138.6, 131.9, 131.0,

128.8, 128.8, 128.6, 128.0, 127.8, 127.6,127.3,53.0,(51.3,51.1), 46.5,44.7,42.3;
Anal. Calcd for C 23H 22O 5 : C, 73.00; H, 5.86. Found: C, 72.83; H, 6.08.
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2.10

3-Methoxyoxalyl-bicyclo[2.2.1]hept-5-ene-2-carboxylic acid methyl ester (2.10)

Two methods were used to prepare compound 2.10, which is isolated as a mixture o f
diastereomers:
A. To a solution o f DOG (3.00 g, 14.5 mmol) in benzene (25 mL) at 0 °C was added
freshly cracked cyclopentadiene dimer (> 1.75 mL, 20.94 mmol) and the reaction was
complete upon addition as determined by TLC analysis. The solvent was removed in
vacuo and the resultant clear/yellow oil was chromatographed (SiOi, 25% EtOAc :
hexanes) to afford the product 2.10 (3.57 g , 85.8 %) as a clear/yellow oil:
B. To a solution o f DOG (0.44 g, 2.5 mmol) in CH 2CI2 (10 mL) at rt was added freshly
cracked cyclopentadiene dimer (> 0.425 mL, 5.1 mmol) and the solution was stirred for
10 min. The solvent was removed in vacuo and the resultant clear/yellow oil was
chromatographed (Si02,25% EtO A c: hexanes) to afford (2.7.a) (0.05 g , 90.2%) as a
yellow oil:
'H NMR (CDCI3, 400 MHz):

8

6.31 (dd, J - 3.1, 5.7 Hz, 0.5 H), 6.23 (dd, J = 3.1,

5.7 Hz, 0.5 H), 6.10 (dd, J = 2.5, 5.7 Hz, 0.5 H), 5.91 (dd, J = 2.5, 5.7 Hz, 0.5 H), 3.96,
(d d ,y = 3.5,4.5 Hz, I H), 3.86 (s, 1.5 H), 3.83 (s, 1.5 H), 3.67 (s, 1.5 H), 3.60 (s, 1.5 H),
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3.44-3.39 (m, 1 H), 3,26 (s, 0.2 H) 3.14 (s, 0.8 H), 2.72 (dd, J = 1.6,4.8 Hz, 1 H); 1.71 (d,
J - 8.8 Hz, 0.5 H); 1.48 (d d ,./= 1.6, 8.8 Hz, 0.5 H), 1.38 (s, 1 H);
13C NMR (CDCU, 100 MHz): 5 (194.3, 193.4), (175.0, 173.8), (162.1, 162.0)
(138.3, 137.5), (136.2, 134.4), (53.1, 52.8), 52.0, 51.7, (47.7,47.6), (46.2,46.1), (45.9,
45.6), 45.1
IR (liquid cell, CDC13)3155, 2986,2956, 1727, 1438, 1381, 1253, 1091 cm '1;
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2.11

Methyl 3-methoxyoxalyl-bicyclo(2.2.2]oct-5-ene-2-carboxylate (2.11)

Two methods were used to prepare compound 2.11, which was isolated as a diastereomer
mixture:
A. To a solution o f DOG (0.742 g, 4.27 mmol) in benzene (6 mL) was added 1,3cyclohexadiene (0.577 mL, 8.52 mmol) and the resulting solution was heated to reflux
and stirred for 24 h. The solvent was removed in vacuo and the resultant brown oil was
chromatographed (Si02.25% EtOAc : hexanes) to afford the compound 2.11 (0.63 g,
58.1%) as mixture o f endo/exo isomers as a gold oil:
B. To a sealable pressure tube was added DOG (1.51 g, 8.78 mmol), 1,3-cyclohexadiene
(1.25 mL, 13.17 mmol) and benzene (10 mL). The solution was heated to 150 0 C and
stirred for 72 h. The solvent was removed in vacuo and the resultant black tar was
chromatographed (Si02, 25% EtOAc : hexanes) to afford compound 2.11 (1.84 g, 82.5%)
as a gold oil:
lH NMR (CDCI3 , 400 MHz): 8 6.33 (t, J = 8.3 Hz, 1 H), 6.22 (t, J = 7.6, 1 H),
3.85 (s, 3 H), 3.83 (s, 3 H), 3.78 (dd, J - 1.9,5.7 Hz, 1 H), 3.17 (dd, J - 1.9, 5.4 Hz, 1 H),
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3.00-2.89 (m, 2 H), 1.78-1.70 (m, 1 H), 1.58-1.50 (m, 1 H), 1.36-1.27 (m, 1 H), 1.17-1.09
(m, 1 H);
l3C NMR (CDC13, 100 MHz): 8 (195.2, 194.4), (175.2, 174.9), 162.8, (136.2,
135.1), (134.2, 132.3), (54.1, 54.0), (53.2, 53.1), (51.5, 50.7), (44.6,44.3), (33.4, 33.2),
(32.8, 32.6), (25.9, 25.1), (21.5,21.0);
IR (liquid cell, CDCb) 3156, 2955, 1728, 1466, 1437, 1382, 1273, 1225, 1094

cm'1;
Anal. Calcd for Ci3H |60s: C, 61.90; H, 6.39. Found: C, 61.99; H, 6.41.

69

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

o

OP
furan

c o 2c h 3

Q

c o 2ch 3

o

c o 2c h 3

sealed
tube

H3 C 0 2 C‘
2.3

2.12

Methyl 3-methoxyoxalyl-7-oxa-bicyclo[2.2.1]hept-5-ene-2-car boxy late (2.12)

Three methods were used to prepare compound 2.12:

A. To a sealable pressure tube was added DOG (0.415 g, 2.39 mmol) and furan (5 mL)
as the solvent. The solution was heated to 120 °C and stirred for 72 h. The solvent was
removed in vacuo and the resultant black tar was chromatographed (S i0 2, 33% EtOAc :
hexanes) to afford the product 2.12 (0.14 g, 24.8%) as a yellow oil.

B. To a solution o f DOG (0.50 g, 2.88 mmol) in CH2C12 (10 mL) was added fiuran (0.69
mL, 14.40 mmol) and the resulting solution was heated to reflux and stirred for 14 h. The
solvent was removed in vacuo and the resultant yellow oil was chromatographed (Si02,
25% EtOAc : hexanes) to afford the product 2.12 (0.06 g, 8.0%) as a gold oil.

C. To a solution o f DOG (0.504 g, 2.93 mmol) and fiiran (0.703 mL, 14.67 mmol) in
CH2C12 (25 mL) was added A1C13 (ca. 0.1 g) and the resulting solution turned black in 5
min. The reaction mixture was filtered through a pad o f Celite, the solvent was removed
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in vacuo and the brown oil was chromatographed (SiCh, 25% EtOAc : hexanes) to afford
the product 2.12 (0.47 g, 66.7%) as a gold oil:
'H NMR (CDC13, 400 MHz): 8 7.34 (dd, J - 0.6, 1.9 Hz, 1 H), 6.32 (dd, J - 1.9,
3.5 Hz, 1 H), 6.21 (d, J = 3.5 Hz, 1 H), 4.29 (dd, J = 4.6,9.7 Hz, 1 H), 3.88 (s, 3H), 3.77
(dd, J - 9.8, 19.0 Hz, 1 H), 3.72 (s, 3 H), 3.24 (dd, J - 4.8, 19.0 Hz, I H);
13C NMR (CDClj, 100 MHz) 8 192.1, 171.9, 161.5, 150.8, 143.2, 111.2, 108.0,
53.5, 53.1,40.4,40.0;
IR (liquid cell, CDCb) 3154, 1793, 1735, 1472, 1382, 1095 c m 1;
Anal. Calcd for C 11H 12O6 : C, 55.00; H, 5.04. Found: C, 55.05; H, 5.09
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Methyl 3-methoxyoxalyl-4-methyl-7-oxa-bicyclo(2.2.1lhept-5-ene-2-carboxyIate
(2.13)

To a solution o f DOG (1.05 g, 6.11 mmol) in CH 2CI2 (25 mL) was added 2-methylfuran
(2.76 mL, 30.55 mmol) and the resulting solution was heated to reflux and stirred for 14
h. The solvent was removed in vacuo and the resultant gold oil was chromatographed
(Si02.25% EtOAc : hexanes) to afford the product 2.13 (1.54 g, 99.0%) as a gold oil:

'H NMR (CDCI3, 400 MHz): 8 6.05 (d, br, J - 3.2 Hz, 1 H), 6.04 (dd, br, J - 3.2,
1.0 Hz, 1 H), 4.21 (dd, J = 4.5,10.0 Hz, 1 H), 3.85 (s, 3 H), 3.73 (dd, J = 10.0, 19.1 Hz, 1
H), 3.68 (s, 3 H), 3.18 (dd, J = 4.5, 19.1 Hz, 1 H), 2.23 (s, 3 H);
I3CNMR(CDC13, 100 MHz): 8 191.1, 171.0, 160.5, 152.0,147.9, 107.9, 106.3,
53.0, 52.6,40.2, 39.7, 13.4
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Dimethyl 9,10-dihydroanthraceno-3,10-[3,4-(2-oxo)]-giutarate (2.16)

To a sealable pressure tube was added DOG (l.SS g, 9.02 mmol), anthracene (1.78 g ,
10.0 mmol) and benzene (30 mL). The solution was heated to ISO °C and stirred for 48
h. The heat was removed, the tube was opened and the unreacted anthracene was
removed by filtration. The mixture was recrystallized with benzene to remove more
anthracene and the mother liquor was chromatographed (Si02, 25% EtOAc : hexanes) to
afford the compound 2.16 (2.22 g, 67.4 %) as a yellow solid:
m.p. 131-133 °C;
lH NMR (CDCI3, 400 MHz):

8

7.25 (m,

8

H), 4.84 (d, J - 2.5 Hz, 1 H), 4.79 (d, J

= 2.5 Hz, 1 H), 4.08 (dd, J - 1.9, Hz, 1 H), 3.93 (s, 3 H), 3.63 (s, 3 H), 3.48 (dd, J - 3.2,
5.1 Hz, 1 H);
l3CNM R(CDCl3, 100 MHz): 5 192.8, 173.3, 162.4, 142.7, 142.4, 141.2, 139.7,
127.5, 127.2, 127.2,125.5,125.3, 124.5,124.4,53.4,52.5,46.7,46.3,46.2;
IR (liquid cell, CDCI3) 1730.1, 1260.5, 1221.9,1087.7 cm*1;
Anal. Calcd for C 2 IH l80 5: C, 71.99; H, 5.18. Found: C, 71.17; H, 5.14.
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Methyl 6-methoxyoxalyl-4-methyl-cyclohex-3-enecarboxyIate (2.19.a) and
Methyl 6-methoxyoxalyl-3-methyl-cyclohex-3-enecarboxylate (2.19.b)

To a sealable pressure tube was added DOG (0.53 g, 3.09 mmol), isoprene (1.55 mL,
15.45 mmol) and CH 2C12 (30 mL). The solution was stirred at rt for 1 h and subsequently
heated to 75 °C and stirred for 0.5 h. The solvent was removed in vacuo and the resultant
oil was chromatographed (S i02, 25% EtOAc : hexanes) to afford the products (2.19.a and
2.19.b) as a mixture o f regioisomers (0.71 g, 95.4 % combined). A 64 : 36 regioisomer
ratio was determined for the crude isolate by integration o f the ester a-protons doublets
o f triplets arising at 2.92 and 2.83 ppm in the 'H NMR, respectively.
'H NMR (CDC13, 400 MHz):

8

5.31 (s, 1 H), 3.80 (d, 3 H), 3.61-3.44 (m, 4 H),

2.92 (td, J = 5.8, 11.6 Hz, 0.64 H), 2.83 (td, J = 5.8, 11.6 Hz, 0.36 H), 2.42-1.88 (m, 4 H),
1.59 (s, 3 H);
l3CNM R(CDCl3, 100 MHz):

8

198.5, 198.3, 176.9, 176.8, 163.0, 163.0, 134.1,

133.9, 120.8, 120.4, 54.2,53.4,45.0,45.6,43.4,42.9, 33.5, 33.4,24.1
HRMS Calcd for C 12H it05: 241.1076. Found: Pending.
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2.20

Methyl 3-methoxyoxaly l-4-[(2,2,2-trifluoro-acetylamino)-niethyl|-7-oxa
bicyclo[2.2.1 ]hept-S-ene-2-carboxy late (2.20 )

To a solution of DOG (0.46 g, 3.0 mmol) in CH2CI2 (15mL) was added compound 2.50
N-trifluoroacetylfurfuralamine (0.57 g, 3.0 mmol) and the resulting solution was stirred at
rt forlO min. The solvent was removed in vacuo and the resultant gold oil was
chromatographed (S i02, 25% EtOAc : hexanes) to afford the product 2.20 (0.83 g, 84.0
%) as a gold oil:

lH NMR (CDCI3, 400 MHz): 5 7.49 (br, t, 1 H), 6.13 (d, J - 3.2 Hz, 1 H), 6.06 (d,
J - 3.2 Hz, 1 H), 4.36 ( d , / = 5.8 Hz, 2 H), 4.14 (dd,.7=9.1, 5.2 Hz, 1 H ),3 .7 7 (s,3 I3C
NMR (CDCI3, 100 MHz) 8 191.9, 170.7, 160.2, 156.9 ( q ,/ C-F = 36.6 Hz), 149.8, 148.6,
109.6, 108.2, 53.0, 52.5,39.9,39.5,36.4 (2 C)
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xf

C 0 2 CH3

h 2 noh> hci
NaOAc* 3H2o '

C0 2 CH3
H
2.8

CO2 CH3

C0 2CH3

Methyl 6-(Hydroxyimino-methoxycarbonyl-inethyl)-3,4-diinethyl-cyclohex-3enecarboxylate (2.21 )

To a solution o f ketoester 2.8 (0.33 g, 1.30 nunol) in absolute ethanol ( 6 mL) was added
hydroxylamine hydrochloride (0.09 g, 1.20 mmol) and sodium acetate trihydrate (0.18 g,
I.30 mmol) and the resultant solution was stirred at rt for 21 h, heated to reflux and
stirred an additional 3.5 h. The EtOH was removed in vacuo and the residue was
partitioned between CH 2CI2 (10 mL) and brine (10 mL). The organic layer was collected
and the aqueous was subsequently extracted with CH2CI2 (3 x 1 0 mL), dried (MgSCU),
filtered and the solvent was removed in vacuo to afford the crude product (0.32 g) as a
white solid. Recrystallization from EtOH afforded the product 2.21 (0.15 g, 41.5 % as a
white solid.
'H NMR (CDCI3, 400 MHz): 8 3.78 (s, 3 H), 3.58-3.50 (m, 4 H), 3.39 (td, J =
II.7 Hz, J - 5.8 Hz, 1 H), 2.45-2.38 (br t, 1 H), 2.24-2.09 (br m, 2H), 2.01-1.95 (br m, 1
H), 1.60-1.58 (brd,

6

H);

,3C NMR(CDC13, 100 MHz): 5 176.2,164.6, 154.0, 125.1, 124.6, 52.8, 52.1,
41.7,35,2,35.1,33.!, 18.8, 18.6;
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o

c h 2ci 2
c o 2c h 3

(CH3)2NNH2

n “n 'c h 3
c o 2c h 3

HOAc

*^C02CH3

•j C0 2CH3
2.7

2.22

Methyl 6-[(dimethyl-hydrazono)-methoxycarbonyl-methyl]-cyclohex-3
enecarboxylate (2 .22 )

To a solution o f ketoester 2.7 (4.42 g, 19.57 mmol) in CH2CI2 (25 mL) was added HOAc
(3.26 mL, 58.70 mmol) and the solution was stirred at rt for 5 min. To the resultant
solution was added N,N-dimethylhydrazine (7.42 mL, 97.83 mmol) and the solution was
heated to reflux and stirred for 24 h. The CH2CI2 and HOAc were removed in vacuo and
the resultant slurry was triturated with CH 2CI2 and filtered through a pad (40 g) o f silica
gel (CH 2CI2 ; 50 mL) then 50% EtOAc : hexanes (200 mL). The solvent was removed in
vacuo and the resultant yellow oil was chromatographed (Si0 2 , 50% EtOAc : hexanes) to
afford the compound 2.21 (4.48 g, 77.4%) as a yellow oil:
lH NMR (CDCI3, 400 MHz):

8

5.53 (d, J - 3.2 Hz, 2 H), 3.65 (s, 3 H), 3.51 (s, 3

H), 2.81 (td, J - 5.2, 11.0 Hz, 1 H), 2.68 ( td ,/= 5.2, 11.0 Hz, 1 H); 2.46 (s, 6 H), 2.291.87 (m, 4 H);
l3C NMR (CDCI3, 100 MHz) 8 176.1, 165.9, 151.8, 125.7, 125.1, 51.6, 51.3,47.3,
47.2, 39.9,39.8,29.6,28.8;
IR neat 3025,2951-2850, 1736, 1293-1126 cm;
Anal. Calcd for C 13H 20N2O 4 *.C, 58.19; H, 7.51; N, 10.44. Found: C, 58.16; H,
7.59; N, 10.25;
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HRMS Calcd for Q 3H20N 2O4 269.1501. Found: 269.1493 (M+H)
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c h 2ci 2
C0 2CH3

(CH3)2NNH2
HOAc

n c o 2c h 3

Y

c o 2c h 3

T " c o 2c h 3

2.8

2.23

Methyl 6>[(dimethyl-hydrazono)-methoxycarbonyl-methyl]-3,4-dimethyl-cyclohex3-enecarboxylate (2.23)

To a solution of keto diester 2.8 (S.67 g, 22.34 mmol) in CH 2CI2 (25 mL) was added
HOAc (3.72 mL, 67.01 mmol) and the solution was stirred at rt for 5 min. To the
resultant solution was added unsymmetrical N,N-dimethylhydrazine (8.47 mL, 111.6 8
mmol) and the solution was heated to reflux and stirred for 24 h. The CH 2CI2 and HOAc
were removed in vacuo and the resultant slurry was triturated with CH 2CI2 and filtered
through a pad (80 g) o f silica gel with CH2CI2 (100 mL) then 50% EtOAc : Hexanes (600
mL). The solvent was removed in vacuo and the resultant yellow oil was
chromatographed (Si0 2 , 50% EtOAc : hexanes) to afford the product 2.23 (6.02 g,
91.1 %) as a yellow oil:
‘H NMR (CDCi3, 400 MHz):

8

3.70 (s, 3 H), 3.56 (s, 3 H), 2.84 (td, J = 5.5, 11.0,

1 H), 2.65 (td, 7 = 6 .5 , 11.00, 1 H), 2.49 (s, 6 H), 2.16-1.91 (m, 4 H), 1.51 (s, 6 H);
13C NMR (CDCI3, 100 MHz): 8 177.6,167.4, 154.7, 125.9, 125.4,53.0, 52.6,
48.7,48.6,44.5,42.0,37.1,36.4,19.7,19.6;
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Anal. Calcd for C isHmNsO*: C, 60.79; H, 8.16; N, 9.45. Found: C, 60.62; H,
8.04; N, 9.50.
HRMS Calcd for Q 5H25N 2O4 297.1814. Found: 297.1810 (M+H)+.
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C 0 2 CH3

C 0 2 CH3
CH2CI2

(CH3 )2 NNH2

°= \
CO2 CH3

HOAc

H*C'N \
CH3

CO2CH3

2.24

2.10

Methyl 3-[(Dimethyl-hydrazono)-methoxycarbonyl-methyl]-bicyclo [2.2.1 ]hept-5ene-2-carboxylate (2.24)
To a solution o f ketoester 2.10 (2.03 g, 8.52 mmol) in CH 2CI2 (20 mL) was added HOAc
(1.42 mL, 25.57 mmol) and the solution was stirred at rt for 5 minutes. To the resultant
solution was added N,N-dimethylhydrazine (3.23 mL, 42.61 mmol) and the solution was
stirred at rt for 5 h when TLC indicated consumption o f starting material. The solvent,
HOAc and hydrazine were removed in vacuo and the resultant yellow oil was
chromatographed (Si0 2 , 25% EtOAc : hexanes) to afford 2.24 (2.14 g, 89.5 %) as a
yellow oil, as a lH NMR discriminable mixture o f E / Z isomers:
H NMR (CDCI3, 400 MHz): §6.13 (dd, J - 5.8,3.2 Hz, 0.3 H), 6.07 (dd, J - 5.8,
3.2 Hz, 0.7 H), 5.93 (q, J = 5.8,3.2 Hz, 0.3 H), 5.90 (q, J - 5.8, 3.2 Hz, 0.7 H) 3.67 (s,
0.9 H), 3.66 (s, 2.1 H), 3.57 (s, 2.1 H), 3.50 (s, 0.9 H) 3.42 (t, J = 3.9 Hz, 0.3 H), 3.29 (t,
J = 3.2 Hz, 0.7 H), 3.08 (br s, 0.3 H), 2.98 (br s, 0.7 H), 2.93 (br s, 0.7H), 2.90 (br s, 0.3
H), 2.70 (dd, J = 4 . 5 , 1.9 H z ,0.7 H), 2.63 (dd, J = 4 . 5 , 1.9 Hz, 0.3 H) 2 .4 4 (s, 1.8 H), 2.38
(s, 4.2 H), 1.52 ( b d t,7 = 9.1 Hz, 1H), 1.32 (brt,

9.1,3.9, 1.9 Hz, 1 H));
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13C NMR(CDC13, 100 MHz) 5 176.0, 167.0, 154.9, 136.8, 135.5, 51.9,51.6,47.4,
47.0,46.9,46.5,46.3,45.7,45.4;
HRMS Calcd for Ci^feiNiCU 281.1501. Found: 281.1492 (M+H)+.
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2

’

2.25

2.11

M ethyl 3-[(Dimethyl-hydrazono)-methoxycarbonyl-methyl]-bicycIo[2.2.2]oct-5-ene2-carboxylate (2.25)

To a solution o f keto diester (2.11) (3.61 g, 14.20 mmol) in CH 2CI2 (30 mL) was added
HOAc (2.37 mL, 42.60 mmol) and the solution was stirred at rt for S min. To the
resultant solution was added N,N-dimethylhydrazine (5.39 mL, 71.00 mmol) and the
solution was heated to reflux and stirred for 2 h. The CH2C12 and HOAc were removed
in vacuo and the resultant slurry was triturated with CH 2CI2 and passed through a pad of
silica gel (1% MeOH : CH 2CI2). The solvent was removed in vacuo and the resultant
yellow oil was chromatographed (Si02,25% EtOAc : hexanes) to afford 2.25 (3.61 g,
86.4%) as a yellow oil:
lH NMR (C D C I 3, 400 MHz): 8 6.25 (br t, J - 7.1 Hz, 1 H), 6.06 (br t, / = 7.1, 1
H), 3.71 (s, 3 H), 3.64 (s, 3 H), 3.18 (dd, J - 6.5,2.6 Hz, 1 H), 2.95 (m, 1 H), 2.84 (m, I
H), 2.72 (m, 1 H), 2.42 (s, 6 H), 1.58 (m, I H), 1.47 (m, 1 H), 1.24 (m, I H), 1.07 (m, 1
H);
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l3C NMR (CDCls, 100 MHz):

8

175.8, 167.5, 158,6, 134.6, 133.4, 52.9, 52.7,

48.6,48.5,46.2,45.1,33.9,26.1,25.8, 21.7
HRMS Calcd for Q 5H23N 2O 4 2 9 5 .I 6 5 8 . Found: 295.1666 (M +H f.
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2.22

2.26

2.27

Methyl 3-oxo-2,3,3a,4,7,7a-hexahydro-lH-isoindole-l-carboxylate (2.25)
3-Oxo-2,3,3a,4,7,7a-hexahydro-lH-isoindole-l-carboxylic acid (2.26)

To a solution o f hydrazonoester (2.22) (1.24 g, 5.06 mmol) in MeOH : H2O (1 : 1,20
mL) was added sodium hydrosulfite (1.85 g, 11.88 mmol) and the solution was stirred at
reflux for 6.5 h. The MeOH was removed in vacuo and the remaining aqueous solution
was brought to pH 9 with solid potassium carbonate, extracted with Et20 (3 x 50 mL),
dried (Na2 S0 4 ) and filtered. The solvent was removed in vacuo and the resultant brown
oil was chromatographed (S i02, 5% MeOH : CH 2C12) to afford 2.26 (0.26 g, 25.8%) as a
tan oil:
lH NMR (CDCI3, 400 MHz): 5 5.70-5.62 (m, 2 H), 4.07 (m, 1 H), 4.31-3.83 (m, 3
H), 2.43-1.75 (m, 6 H);
,3C NMR(CDC13, 100 MHz):

8

179.5, 173.1, 128.3, 128.0,61.4,53.8,45.0,44.9,

30.4,26.8;
HRMS Calcd for C l0Ht4NO 3 196.0974. Found: 196.0973 (M +Hf.
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The remaining aqueous layer was brought to pH 3 with 6 N HC1, extracted with Et2 0 (3 x
SO mL), dried over MgS (> 4 and filtered. The solvent was removed in vacuo and the
resultant yellow/white solid was triturated with Et2 0 and the solid was collected by
filtration to afford 2.27 (234 mg, 25.5%) as a white solid:
lH NMR (CDC13, 400 MHz):

8

7.88 (s, 1 H), 5.72-5.66 (m, 2 H), 4.04-3.87 (m, 1

H), 2.31-2.08 (m, 4 H), 1.95-1.77 (m, 2 H);
13C NMR (CDC13, 100 MHz):

8

178.6, 175.1, 129.0, 128.8, 61.2,45.0,44.5, 30.3,

27.3;
HRMS Calcd for C 9H, 2N 0 3 182.0817. Found: 182.0819 (M +H f.
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2.28

2.29

Methyl 5,6-Dimethyl-3-oxo-2,3,3a,4,7,7a-hexahydro-lH-isoindole-l-carboxylate
(2.27)
5,6-Dimethyl-3-oxo-2,3,3a,4,7,7a-hexahydro-lH-isoindole-l-carboxylic acid (2.28)

To a solution o f hydrazonoester (2.23) (1.40 g, 4.71 mmol) in MeOH : H2O (1 : 1, 20
mL) was added sodium hydrosulfite (2.09 g, 13.42 mmol) and the solution was stirred at
reflux for 12.5 h. The MeOH was removed in vacuo and the remaining aqueous solution
was brought to pH 9 with solid potassium carbonate, extracted with EtiO (3 x 50 mL),
dried (Na2 S0 4 ) and filtered. The solvent was removed in vacuo and the resultant brown
oil was chromatographed (Si0 2 , 5% MeOH : CH2CI2) to afford 2.28 (0.23 g, 21.6%) as a
tan oil.
H NMR (CDCI3, 400 MHz): S 6 .8 6 (s, 1 H), 3.95 (d, J = 9.7,
2.30-1.96 (m, 6 H), 1.62 (s,

6

1

H), 3.74 (s, 3 H),

H);

I3C NMR (CDC13, 100 MHz); 5 178.4, 172.1, 126.19, 125.9, 60.2, 52.7,44.5,
35.4,31.5, 19.3;
HRMS Calcd fo rC 12Hl8N 0 3 224.1287. Found: 224.1281 (M +H f.
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The remaining aqueous layer was titrated to pH 3 with 6 N HC1, extracted with Et2 0 (3 x
SO mL), dried (MgSCL) and filtered. The solvent was removed in vacuo and the resultant
yellow/white solid was triturated with EtiO and the solid was collected by filtration to
afford 2.28 (0.30 g, 29.7%) as a white solid:
*H NMR (CDClj, 400 MHz):

8

7.83 (s, 1 H), 4.01-3.85 (m, 2 H), 4.04-3.87 (m, 1

H), 2.25-1.99 (m, 4 H), 1.60 (s, 6 H);
13C NMR (CDCI3, 100 MHz):

8

178.6,175.2, 127.5, 127.3, (61.1, 60.9), 45.7,

45.3, 36.5, 33.2,20.8;
HRMS Calcd for C ,,Hl6N 0 3 210.1130. Found: 210.1139 (M+H)+.
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MeOH/H20

2.25

2.30

Methyl 3-(amino-methoxycarbonyl-methyl)-bicyclo[2.2.2]oct-5-ene-2-carboxylate
(2.30)

To a solution o f hydrazono ester (2.25) (1.23 g, 4.19 mmol) in MeOH (10 mL) was added
water (10 mL) and the resultant suspension was heated to reflux and Na 2S 2C>4 was added
in one portion and the resultant solution was stirred for 4 h. The MeOH was removed in
vacuo and the resultant slurry was partitioned between Et20 (20 mL) and water (20 mL)
and the pH was adjusted to ca. 9 with K2C 0 3 (10%, aqueous) and extracted with Et20 (4
x 20 mL), dried (MgS(>4 ) and concentrated in vacuo to afford the crude amino diester
(2.29) (0.90 g, 85.1 %) as a yellow semisolid. This material is used directly in the
saponification reaction without further purification.

ESI-MS indicates 1 major product with an m/z o f 254 which corresponds to the product
amino diester.
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2.24

2.31

Methyl 3 -( 4 nuno-methoxycarbonyl-methy l)-bicyclo[2.2.1]hept-5-ene-2-carboxylate
(2.30)

To a solution o f hydrazono ester (2.24) (0.95 g, 3.39 mmol) in MeOH (10 mL) was added
water (10 mL) and the resultant suspension was heated to reflux when Na 2S20 4 (1.43 g,
9.14 mmol) was added in one portion and the resultant solution was stirred for 4 h. The
MeOH was removed in vacuo and the resultant slurry was partitioned between Et20 (20
mL) and water (20 mL) and the pH was adjusted to ca. 9 with K2CO 3 (10%, aqueous) and
extracted with Et20 (3 x 20 mL), dried (MgS0 4 ) and concentrated in vacuo to afford the
crude amino diester (2.31) (0.76 g, 93.7 %) as a yellow semisolid. This material is used
directly in the saponification reaction without further purification.

ESI-MS indicates 1 major product with an m/z of 240 which corresponds to the product
amino diester.
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2.32

6-<Ainino-carboxy-methyl)-cyclohex-3-enecarboxyUc acid (2.31)

To a solution o f lactam ester (2.26) (0.22 g, 1.13 mmol) in MeOH (10 mL) and water (4
mL) was added NaOH (2 N, 6.21 mL) and the resultant solution was stirred at rt for 10
min. The solution was heated to reflux and stirred for S h, cooled to rt, stirred an
additional 12 h, re-heated to reflux and stirred for 3 h (HPLC/MS indicated consumption
o f starting materials). The solution was cooled to rt and the MeOH was removed in
vacuo. The aqueous was titrated to pH 3 with 6 N HC1 and washed with Et2 0 (20 mL)
and loaded onto an ion exchange (Bio-Rad, AG-1X2, acetate form)column. The column
was eluted with 1 N HC1 to afford 232 (0.IS g, 58.0 %) as a white solid.
lH NMR (D20 , 400 MHz):

8

5.74-5.65 (br m, 2 H), 4.24 ( d ,J = 3.2 Hz, 0.5 H),

4.07 (d, 7 = 3.2 Hz, 0.5 H), 2.90-2.05 (br m, 2 H), 2.57-2.35 (br m, 3 H), 2.29-2.16 (br m,
2 H), 2.07 (br s, 1H);
l3C NMR(CDC13, 100 MHz): 8 179.9, 179.7, (126.5, 126.3), (126.1, 125.6),
(56.6, 55.8), (43.1,42.2), (37.0, 36.8), (30.3,29.3), (26.1,25.6)
HRMS Calcd for C9H 14NO 4 200.0923. Found: 200.0918 (M + H f.
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2.33

6-(Amino-carboxy-methyl)-3,4-diinethyl-cyclohex-3-enecarboxylic acid (2.33)

To a solution o f lactam acid 2.29 (0.10 g, 0.47 mmol) in THF/water (1 : 1, 10 mL) was
added NaOH (2 N, 2.34 mL, 4.67 mmol) and the reaction was heated to 50 °C and stirred
for 7 h followed by stirring at rt for 10 h. The THF was removed in vacuo and the
remaining aqueous was titrated to pH 3 with 6 N HC1 and stirred for 15 min. The
solution was washed with Et2 0 (3 x 20 mL) and the remaining aqueous layer was added
to an ion exchange (Bio-Rad, AG-1X2, acetate form) column. Elution with 1 N HC1
afforded 2.33 (0.09, 85.2 %) as an off white solid:
‘H NMR (D20 , 400 MHz):
1.37 (br m,

6

6

3.73-3.67 (br m, 1 H), 2.17-1.61 (br m,

6

H), 1.56-

H)

l3C N M R(D 20 , 100 MHz):

6

182.14, 179.35, 127.58, 126.52, 71.45, 64.08,

(45.93,45.26), 35.40,31.91, 19.44:
HRMS Calcd for CuHigNOt 228.1236. Found: 228.1236 (M +H f.

92

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

c o 2h

1. NaOH

2. Ion Exchange

f

t

2.34

2.30

3-(Amino-carboxy-metliyl)-bicyclo[2.2.2]oct-5-ene-2-carboxylic acid (2.34)

To a solution of amino diester (2 JO) (0.180 g, 0.712 mol) in MeOH (2.5 mL) was added
NaOH ( 6 N, 475 pL, 2.847 mmol) and the resultant solution was stirred at rt for 30 min
and subsequently heated to reflux and stirred for 5 min. The solution was cooled to rt and
the MeOH was removed in vacuo. The remaining aqueous solution was brought to ca.
pH

6

with 1 N HC1 and loaded to an ion exchange (Bio-Rad, AG-1X2, acetate form)

column and the amino acid eluted with 0.25 - 0.5 N HC1, the solvent was removed in
vacuo to afford 2 J 4 (185.3 mg, 99.5%) as a white solid.
lH NMR (CDCI3, 400 MHz): 5 6.68-6.57 (m, 1 H), 6.41-6.34 (m, 1 H), 4.12 (d, J
= 4.8 Hz, 0.6 H), 3.78 (d, J = 9.7 Hz, 0.4 H), 3.10-3.09 (m, 1 H), 2.89-2.66 (m, 3 H),
1.73-1.24 (m, 4 H);
,3C NMR (CDCU,

100

MHz):

8

(179.7, 179.4), (173.8, 173.2), (138.0, 137.7),

(133.6, 132.9), (58.2,57.9), (49.0,48.6), 47.2, (42.8,42.6), (32.3, 31.8), (26.8,26.3),
2 0 .1;
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2.35

3-(Amino-carboxy-methyl)-bicyclo[2.2.1]hept-5-ene-2-carboxyIic acid (2.34)

To a solution o f amino diester (2.31) (0.40 g, 0.15 mol) in MeOH (2.5 mL) was added
NaOH (6 N, 101 |iL, 0.61 mmol) and the resultant solution was stirred at rt overnight.
The MeOH was removed in vacuo and the remaining aqueous solution was titrated to ca.
pH 6 with 6 N HC1. The crude amino acid was loaded onto an ion exchange (Bio-Rad,
AG-1X2, acetate form) column and the amino acid eluted with 0.25 N HC1. The solvent
was removed in vacuo to afford 2.35 (0.03 g, 75.7%) as a white solid.

‘H NMR (CDCI3, 400 MHz):

8

6.35-5.98 (m, 2 H), 3.41 (br d, 7 = 10.4 Hz, 0.5

H), 3.28 (br d, J = 11.6 Hz, 0.5 H), 3.02 (br s, 1 H), 2.94 (br s, 1 H), 2.69-2.59 (br m, 1
H), 2.27 (br s, 0.5 H), 2.14 (br s, 0.5 H), 1.43-1.35 (br m, 2 H);
l3CN M R(CD Cl3, 100 MHz): 8 (180.0, 180.1), (173.8, 173.2), (141.6, 139.7),
(136.5,134.5), (58.4, 57.3), (49.4,48.9), (48.6,48.5), (47.7,47.5), (46.9,46.2), (45.7,
45.1);
HRMS Calcd for CioHt4N 0 4 212.0923. Found: 212.0914 (M+H)+.
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2.3

2.36

Methyl l-dimethylamino-3-inetlioxyoxalyl-I,2,3*4-tetrahydro-pyridine-2carboxylate (236)
To a solution o f DOG 2.3 (0.32 g, 1.88 mmol) in CH2C12 (2.S mL) was added a solution
o f acrolein dimethylhydrazone (0.28 g, 2.81 mmol) in CH2C12(2.5 mL) and the resultant
solution was stirred at rt for 3 h. The solvent was removed in vacuo and the crude red oil
was chromatographed (S i02, 50% EtOAc : hexanes) to afford 2.36 (0.21 g, 41.4 %) as a
red oil:
lH NMR (CDCI3, 400 MHz): 8 6.48 (d,J = 5.8 Hz, 1 H), 6.11-6.10 (br m, 1 H),
4.51 (ddd, J = 12.9, 5.2, 1.9 Hz, 1 H), 3.74 (s, 3 H), 3.68 (s, 3 H), 3.43-3.38 (m, 1 H),
2.78 (s, 6 H),2.31-2.24 (m, 1 H), 2.06-1.97 (m, 1 H);
l3C NMR(CDC13, 100 MHz): 8 173.6,164.1, 145.5, 132.0, 109.2, 53.4 (2 C),
44.0,43.5, 39.2,34.8,29.5;
HRMS Calcd for Ci2Hi9N2Os 271.1294. Found: 271.1298 (M +H f.
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l-Dimethylamino-3-methoxyoxalyl-5-metliyl-l,2,3'4-tetraliydro-pyridine-2carboxylic acid methyl ester (2.36)

To a solution o f DOG 2.3 (0.72 g, 4.21 mmol) in CH 2CI2 (10 mL) was added a solution
o f methacrolein dimethylhydrazone (0.28 g, 2.81 mmol) in CH 2CI2 (2 mL) and the
resultant solution was stirred at rt for 4 h. The solvent was removed iin vacuo and the
crude red oil was chromatographed (S i02,25% EtOAc : hexanes) to afford the product
23 5 (0.88 g, 73.3 %) as a red oil:
lH NMR (CDCI3, 400 MHz): § 6.44 (s, 1 H), 6.10 (d, J = 3.2 Hz, 1 H), 3.71 (s, 3
H), 3.64 (s, 3 H), 3.21 (td, J - 8.4, 3.2 Hz, 1 H), 2.67 (s,

6

H), 2.22 (q, J - 14.2, 8.4 Hz, 1

H), 1.99 ( q ,y = 14.2, 7.1 Hz, 1 H), 1.34 (s, 3 H);
l3C NMR (CDCI3, 100 MHz): 5 172.4, 163.2, 142.9, 108.2, 107.1, 52.1, 52.0,
42.5,42.4, 35.8,32.3, 27.2,23.0
HRMS Calcd for Q 3H21N 2O 5 285.1450. Found: 285.1458 (M +H f.
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2.42

Methyl l-benzyl-5-oxo-4-phenylamino-2,5-dihydro-lH-pyrrole-2-carboxylate (2.42)

To a solution of benzyl amine (6.92 mL, 63.41 mmol) in CH2CI2 (20 mL) was added
DOG (2.3) (5.19 g, 30.19 mmol) in CH 2CI2 (30 mL) dropwise over 20 min. The resultant
solution was stirred at rt for 10 min., the solvent was removed in vacuo and the resultant
crude oil was chromatographed (Si02, 25 % EtOAc : hexanes) to afford the 2.42 (6.73 g,
90.2 %) as a yellow oil:
‘H NMR (CDCI3, 400 MHz): £ 7.38-7.19 (m, 10 H), 5.19 (d, J = 14.9, 1 H), 5.06
(d, J - 2.6 Hz, 1 H), 4.36 (d, J - 2.6 Hz, 1 H), 4.26-4.14 (m, 3H), 3.68 (s, 3 H);
l3C NMR (CDCI3, 100 MHz): 6 171.8, 169.8, 142.3, 139.6, 130.6, 130.4, 130.2,
129.5, 129.3,97.5, 61.6, 53.9,46.8;
HRMS Calcd for C2oH2lN203: 337.1552. Found: 337.1542 (M +H f.
HRMS Calcd for C2oH2oN20 3 Na: 359.1372. Found: 359.1388 (M + N af.
HRMS Calcd for C22H23N 3O 3 : 400.1637. Found: 400.1636 (M+CH 3CN + N a f.
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2.41

Methyl 1-benzyl-4,5-dioxo-pyrrolidine-2-carboxylate (2.41)

To a solution o f enamine 2.41 (0.16 g, 0.48 mmol) in wet MeOH (3 mL) was added HC1
( I N , 10 drops) and the solution was stirred at rt for S min. The MeOH was removed iin
vacuo and the resultant slurry was partitioned between Et2 0 (10 mL) and HC1 (0,25 N, 5
mL) and the organic layer was collected and the aqueous layer was extracted with Et2 0
(10 mL), the organics were combined, dried over MgS 0 4 and filtered to afford 2.41 (0.11
g, 93.4 %) as a brown oil:
lH NMR (CDCI3, 400 MHz): $ 7.36-7.24 (m, 5 H), 5.16 (d, J = 14.2 Hz, I H),
4.33-4.27 (m, 2 H), 3.68 (s, 3 H), 2.89-2.82 (m, 1 H), 2.72-2.67 (m, 1 H);
l3C NMR (CDCI3, 100 MHz):

8

196.4, 170.9, 160.0, 134.5, 129.8, 129.6, 129.4,

53.2,47.9,35.2,29.8;
HRMS Calcd for Q 3H 14NO4 : 248.0923. Found: 248.0917 (M +H f.
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2.43

6-Oxalyl-cyclohex-3-enecarboxylic acid (2.43)

To a solution o f 2.7 (0.32 g, 1.44 mmol) in MeOH (2.5 mL) was added NaOH (2 N, 2.0
mL, excess) and the solution was stirred at rt overnight. The MeOH was removed in
vacuo and the aqueous solution was extracted with Et20 ( 3 x 7 mL) then titrated to pH 2
with 6 N HCl and extracted with EtjO (3 x 20 mL), dried (MgS 0 4 ) and the solvent was
removed in vacuo to afford the diacid 2.43 (0.26 g, 90.4 %) as a yellow oil.
‘H NMR (D20 , 400 MHz); 8 7.64 (br s, 2 H), 5.25 (br s, 1 H), 4.77-4.70 (m, 1 H),
4.36-4.30 (m, 2 H), 4.12-4.04 (m, 1 H), 3.95-3.88 (m, 1 H);
13C NMR (D2O, 100 MHz); 8 180.7, 170.9 (2 C), 126.2, 126.0,45.3,41.5, 28.1,
27.0
HRMS Calcd for C9H u0 5 199.0606. Found: 199.0602 (M +H f.
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2.8

3,4-Dimethyl-6-oxalyl-cyclohex-3-enecarboxylic acid (2.44)

To a solution o f 2.8 (0.45 g, 1.76 mmol) in MeOH (3.6 mL) was added NaOH (IN, 3.62
mL, 3.62 mmol) dropwise over 5 min and the resultant solution was heated to 50 °C and
stirred for 48 h. The solvent was removed with a stream of air and the resultant solid was
dissolved in a minimum amount o f water and brought to pH 3 by the addition o f 25%
aqueous TFA. The precipitate was isolated by centrifugation to afford 2.44 (0.40 g,
67.0%) as an off white solid.
‘H NMR (D20 , 400 MHz): 6 3.25 (br s, 1 H), 2.70 (td, J = 10.4, 5.8 Hz, 1 H),
2.21-1.84 (m, 4 H), 1.51 (s, 6 H);
l3C NMR (DzO, 100 MHz): S 180.6, 170.9 (2 C), 125.5, 125.2,46.0, 43.3,42.0,
33.9, 32.7, 18.9, 18.8;
HRMS Calcd for Q flisO s 227.0919. Found: 227.0920 (M+H)+.
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2.45

2.10

3-Oxalyl-bicycIo[2.2.1]hept-5-ene-2-carboxylic acid (2.45)

To a solution o f 2.10 (0.52 g, 2.20 mmol) in MeOH (4.5 mL) was added NaOH (1 N,
4.50 mL, 4.50 mmol) and the resultant solution was stirred at rt overnight. The solvent
was removed in vacuo and the resultant solid was dissolved in a minimum amount of
water and brought to pH 3 by the addition of 25% aqueous TFA. The precipitate was
isolated by centrifugation to afford 2.45 (0.40 g, 67.0%) as a brown solid. 1H NMR
indicates an 80 : 20 mixture o f stereoisomers by integration o f the resolved alkene
protons:
'H NMR (CDCU, 400 MHz) 8 6.26 (q, J - 5.8 Hz, 0.2 H), 6.18 (q, J - 5.8 Hz, 0.8
H), 6.06 (q, J - 5.8 Hz, 0.2 H), 5.92 (q, J - 5.8 Hz, 0.8 H) 3.71 (t, J - 5.2 Hz, 1 H), 3.25
(br s, 1 H), 3.06 (br s, 1 H), 2.54 (d, J - 5.2 Hz, 1 H), 1.53 (br d, J - 9.1 Hz, 1 H), 1.39
(brd, 7 = 9 .1 Hz, 1 H);
13C NMR(CDC13, 100 MHz) 5205.7, 179.6, 171.6, 138.8, 135.4, 54.1, (48.3,
48.2), 47.7,47.1,46.8, (46.4,46.3);
HRMS Calcd for C l0HiiO5 211.0606. Found: 211.0597 (M +Hf.
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2.46

2.11

3-Oxalyl-bicyclo[2.2.2]oct-5-ene-2-carboxylic acid (2.46)

To a solution of 2.11 (0.45 g, 1.79 mmol) in MeOH (2.5 mL) was added NaOH (1 N, 2
mL) and the resultant solution was stirred at it overnight. The MeOH was removed in
vacuo and the remaining aqueous was washed with Et20 ( 3 x 7 mL), adjusted to pH 2
with HC1 (6 N, aqueous) and extracted with Et20 (5 x 20 mL), dried (MgSO<0 and
concentrated in vacuo to afford the diacid 2.44 (0.38 g, 96.6%) as a tan oil:
'H NMR (E^O, 400 MHz): 5 6.53-6.14 (m, 2 H), 3.90-2.90 (m, 4 H), 1.85-1.17
(m, 4 H);
,3C NMR (CDC13, 100 MHz): 6(197.5, 196.8), (177.5, 176.1), (163.5, 163.3),
136.9, 136.2), (134.7,133.5), (50.2,50.1), (44.9,44.5), (33.7, 33.6), (33.0, 32.7), (25.8,
25.2), (21.3, 20.8);
HRMS Calcd for C uH l30 5 225.0763. Found: 225.0763 (M+H)~.
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9,10-Dihydroanthraceno-3,10-[3,4-(2-oxo)]-glutaric acid (2.47)

To a solution o f 2.16 (0.18 g, 0.51 mmol) in MeOH (S mL) was added NaOH (2 N, 2.0
mL) and the solution was stirred at rt overnight. The MeOH was removed in vacuo and
the aqueous was washed with Et20 ( 3 x 7 mL) then titrated to pH 2 with 6 N HC1 and
extracted with Et20 (S x 20 mL), dried (MgS0 4 ) and the solvent was removed in vacuo to
afford 2.47 (0.13 g, 76.8 %) as a white solid.
‘H NMR (CD3CN, 400 MHz): 8 7.41-7.07 (m, 8 H), 4.85 (d, J = 2.6 Hz, 1 H),
4.78 (d, J = 2.6 Hz, 1 H), 4.00 (dd, J = 5.2, 1.9 Hz, I H), 3.32 (dd, J = 5.2, 2.6 Hz, 1 H);
13CN M R(CD 3CN, 100 MHz): § 195.2, 174.6, 162.7, 144.3, 143.9, 142.5, 141.4,
128.2, 126.5, 125.4, 119.0, 52.2,47.6,47.0,46.5
HRMS Calcd for C19H1505 323.0919. Found: 323.0926 (M+H)~.
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Ethyl Succinyl
Chloride

4-(Diethoxy-phosphoryl)-4-oxo-butyric acid ethyl ester (2.48)

To triethylphosphite (3.97 mL, 23.16 mmol) under argon was added ethyl succinyl
chloride (3.00 mL, 21.05 mmol) dropwise. The resultant solution was stirred at rt for 8 h.
The by-products were removed by distillation (below 85 °C, 0.050 mm Hg) and 2.48 was
collected by distillation (98-100 °C, 0.050 mm Hg, 5.37 g, 95.6%) as a colorless oil:
'H NMR (CDCU, 400 MHz):

8

4.12 (m, J - 7.1 Hz, 4 H), 4.03 (q, J - 7.1 Hz, 2

H), 3.04 (td, yP.H= 2.6, J - 6.5 Hz, 2 H), 2.51 (t, J - 6.5 Hz, 2 H), 1.26 (t, J = 7.1 Hz, 6
H), 1.13 ( t,7 = 7.1 Hz, 3 H);
,3C NMR (CDCI3 , 100 MHz): 8 210.0, 208.3, 63.6 (d, JC-p = 6.0 Hz), 60.5, 37.9
(d, J c-p = 57.7 Hz), 26.6 (d, JC-p = 6 .1 Hz); 16.1 (d, Jc.p = 6 .1 Hz), 13.8;
3,P NMR (CDCI3, 161 MHz) 8 -2.7;
HRMS Calcd for C,oH2o06P 267.0998. Found: 267.0993 (M +H f.
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2.48

2.49

4-Oxo-4-phosphono-butyric acid ethyl ester (2.49)

To 2.46 (1.27 g, 4.78 mmol) under argon was added bromotrimethylsilane (5.68 mL,
43.04 mmol) dropwise over 5 min. The resultant solution was stirred at rt overnight. The
excess bromotrimethylsilane and ethyl bromide were removed in vacuo and the
remaining residue was partitioned between water (50 mL) and EtOAc (50 mL). The
aqueous layer was collected and subsequently washed with EtOAc (2 x 50 mL) and the
combined organic fractions were back extracted with water (2 x 20 mL). The combined
aqueous portions were concentrated in vacuo to afford 2.49 as a clear semisolid in about
80% purity as determined by 'H NMR analysis.
lH NMR (D2 0 , 400 MHz): 5 3.41 (q, J - 7.1, 5.2 Hz, 2 H), 2.46 (br t, 2 H), 1.93
(br t, 2 H), 0.50 (br t, 3 H);
l3C NMR (DaO, 100 MHz): 5 218.1 (d, Jc-p = 167.1 Hz); 175.6,62.7,38.3 (d, J c.
P = 51.1 Hz), 27.8, 14.0;
3,P NMR (D2O, 161 MHz): 5 -3.97;
HRMS Calcd for CsH^OfiP 211.0372. Found: 211.0364 (M +H f.
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2.49

trisodium 4-oxo-4-phosphonobutyrate (2.50)

To a solution o f 2.49 (0.28 g, 1.38 mmol) in deionized water (10 mL) was added NaOH
( I N , 4.40 mL, 3.20 mmol) and the resultant solution was heated to 50 °C and stirred
overnight. The solvent was removed in vacuo to afford trisodium 4-oxo-4-phosphonobutyrate, as a clear semisolid, >95% purity as determined by 'H NMR analysis.

H NMR (D20 , 400 MHz): 8 2.94 (t, J - 7.1, 6.5 Hz, 2 H), 2.22 (t, J - 7.1, 6.5 Hz,
2H);
,3C NMR (D 2O, 100 MHz) 8 228.6 (d, JC-p = 156.6 Hz); 183.4,40.4 (d, Jc-p =
42.8 Hz); 31.5 (d, Jc.? = 3.6 Hz);
3lPN M R (D 20, 161 MHz) 8 0.5;
H R M S C a lc d fo rC ^ O e P 180.9902. Found: 180.9904 (M-H)*.
HRMS Calcd for C^sOgN aP 202.9721. Found: 202.9713 (M+Na-H)*.
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2.51

Ethyl 4-(ethoxy-sodium-hydroxy-phosphoryl)-4-oxo-butyrate (2.51)

To a solution o f 2.48 (0.72 g, 2.71 mmol) in acetone (15 mL) under argon was added a
solution o f Nal (0.43 g, 2.84 mmol) in acetone (2 mL) over 10 min. The resultant
solution was heated to reflux and stirred 14 h. Solid Nal (0.43g, 2.84 mmol) was added
in one portion and the resultant solution was heated to reflux and stirred for 6 h when all
starting material was consumed as indicated by TLC. The solvent was removed in vacuo
to afford 2.51 as a pale yellow solid with > 99 % purity as determined by lH NMR
analysis. This material was used in biological assays and additional reactions without
further purification:
‘H NMR (de-acetone, 400 MHz): 8 4.01 (q, J - 7.1 Hz, 2 H), 3.86 (t, J - 7.1 Hz, 2
H), 3.10 (br s, 2 H), 2.54 (b t , / = 5.8,3.9 Hz, 2 H), 1.14-1.10 (m, 6 H):
l3C NMR (de-acetone, 100 MHz): 8 208.6, 174.2, 62.6,61.7,38.2 (d, JC-p = 45.6
Hz), 28.1, 17.3 (d,Jb-p = 6.1 Hz), 14.9;
3lP NMR (de-acetone, 161 MHz): 8 4.7:
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‘H NMR (D20 , 400 MHz): 8 4.05 (q, J - 7.1 Hz, 2 H), 3.85 (p ,7 = 7.1 Hz, 2 H),
3.07 (td, J —6.5, 5.8, 1.9 Hz , 2H) , 2.54 (t, J - 6.5, 5.8 Hz, 2 H), 1.15 (qd, J - 7.1, 1.9 Hz,
6 H):
l3C NMR (D20 , 100 MHz): 5 220.5 (d, Jc-p = 165.1 Hz), 176.2, 63.7 (d, JC-p = 6.1
Hz), 63.0, 39.3, 38.8, 28.2 (d, J c-p = 4.1 Hz), 17.0 (d, Jc.p = 5.1 Hz), 14.4;
3lP NMR (D20 , 161 MHz): 8 1.35:
HRMS Calcd for C8H ,606P 239.0685. Found: 239.0684 (M +H )\

108

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

NaOH

c h 3c h 2o 2c

fPOCH2CH3
O

- Na02C

2.51

^O C H 2CH3
O
2.52

Sodium 4-oxo-4-(ethyl, sodium phosphono)-butanoate (2.52)

To a solution o f 2.49 (1.35 mmol, used directly from the previous reaction) in deionized
water (3 mL) was added NaOH ( I N , 1.35 mL, 1.35 mmol) and the resultant solution was
stirred at rt for 4 h. The solvent was removed in vacuo to afford 2.52 as a yellow oil with
> 95 % purity as determined by lH NMR analysis.
‘H NMR (D20 , 400 MHz): 8 3.95 (m, J - 7.1 Hz, 2 H), 3.07 (t, J - 7.1 Hz, 2 H),
2.41 (m, 2 H), 1.25 (t, J - 7.1, 6.5 Hz, 3 H);
l3C NMR (D20 , 100 MHz): 5 221.8, 183.2,63.9 (d, J C-p = 6.4 Hz), 41.0 (d, J C.P =
46.7 Hz), 31.4 (d, J C-p = 4.2 Hz), 17.5 (d, J C-p = 6.4 Hz);
3,P NMR (D20 , 161 MHz): 8 -0.6.
HRMS Calcd for CfiH^OeP 209.0215. Found: 209.0203 (M-H)‘.
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Chapter 3: Enzymatic transformation of keto diacids to glutamic acid analogues

I. Introduction

Over the past few decades, explosive growth has occurred in the use o f enzymes
in organic synthesis (Davies, 1992). The chemoselectivity, enantioselectivity and, in
general, benign reaction conditions utilized in enzyme-mediated transformations remain
unrivaled by chemical reagents. Some of the most difficult transformations and
assemblies have been accomplished using enzymes at both analytical and preparative
levels. Although enzyme-mediated transformations in organic synthesis hold great
promise, the application o f a given biocatalyst is often limited to a narrow range o f
substrate possibilities. Specifically, only modest structural variation to the natural
substrate is tolerated owing to restrictions in the active site topology. A more thorough
understanding o f the structural limits for potential substrates is often helpful in
determining the synthetic diversity o f an enzyme or enzyme class, and its catalytic
mechanism. The evaluation o f substrate tolerance is especially useful when crystal
structures are lacking or several engineered mutants have been derived that show subtle
variances in activity. Based on the possible favorable outcomes for biocatalysts, it is
important to prepare and screen potential enzyme substrates that have been customtailored with incremental changes in structure such that the rate and extent o f product
formation may be used to derive salient differences in the topographies o f the active sites
among different enzymes. Likewise, the relative rates o f conversion to products and the
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Km values derived from a structurally similar panel o f substrates can reveal important
elements o f the catalytic mechanism.
One o f the most strategically important enzyme-mediated organic reactions is the
conversion o f an a-keto acid to an a-amino acid (Equation 3.1). The substrate a-keto
acids may be obtained by a variety o f chemical and biochemical procedures (Cooper,
1983), but importantly, the product a-amino acid contains a new stereogenic center.

Keto acid product

Amino acid substrate

Ri^.aNH2

Rl'SjjjS-0

Cy ' OH

c t

' oh

Transaminase

OH
Keto add substrate

Amino add product

Equation 3.1: Reaction cycle catalyzed by a transaminase

Because microbiological production of natural a-amino acids is now commonplace, an
interesting challenge at this point is to prepare innovative unnatural a-amino acids. An
important example o f a class o f unnatural a-amino acids resides in the glutamate
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neurotransmitter system in which the conformationally-restricted analogues o f glutamic
acid have been shown to selectively regulate various receptors and transporters
(Chamberlin, 1993). Surprisingly, very few analogues o f glutamic acid have been
prepared via enzyme-mediated syntheses despite the fact that a number o f enzyme
systems are capable o f producing or using glutamic acid. Importantly, in an enzymebased strategy, a single stereoisomer can be produced, a likely structural requirement for
selectivity in the glutamate neurotransmitter system.
The goal o f this section is two fold: (1) to identify an enzyme capable o f
transaminating the 3 ,4-conformationally restricted analogues o f a-ketoglutarate
compounds 2.43 - 2.47, Figure 3.1)] to produce structurally constrained analogues o f Lglutamate with the S configuration at the new stereogenic center, and (2) to test the
ability o f the constrained ketoglutarate analogues to inhibit the action o f certain enzymes.
Due to the principle of microscopic reversibility, if the structurally constrained a-keto
acid is an inhibitor o f an enzyme, it is thought that the product a-amino acid will, in turn,
inhibit the enzymatic transformation. If the a-keto acids are found not to inhibit these
glutamate-utilizing enzymes it is a good indication that these 3,4-conformationally
restricted analogues of L-glutamate will not be metabolized by this system in vivo.
In this section, five 3,4-conformationally restricted analogues o f a-ketoglutarate
(Figure 3.1) were surveyed as substrates o f cytosolic aspartate aminotransferase
(AspAT), alanine aminotransferase (AlaAT), glutamate dehydrogenase (GDH), lactate
dehydrogenase (LDH), a-ketoglutarate dehydrogenase complex (KGDHC), L-leucine
dehydrogenase (LeuDH), glutamine transaminase K (GTK), L-phenylalanine
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dehydrogenase (PDH) and five then^ostable aminotransferases obtained as a kit
(CloneZyme™) from Sigma Chemical company designated as AT-1 through AT-5.

r ^ S ^ C 0 2H
H

> ^ S ^
^

' C 0 2H

2.43

^

c o 2h

t ^co 2h

H
2.44

2.45
.0

2.46

co

2h

2.47

Figure 3.1: 3,4-Conformationally restricted analogues o f a-ketoglutarate

The 3,4-conformationally restricted analogues o f a-ketoglutarate were also testea as
inhibitors o f AlaAT, AspAT, GDH and GTK.
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n.

Results and Discussion

/. Analysis o f Compounds 2.43 —2.47 as Substrates o f L-Amino Acid Dehydrogenases

Because compounds 2.43 - 2.47 (Figure 3.1) are rigid analogues o f aKG, it
seemed possible that they would be substrates o f GDH. Moreover, GDH converts
hydrophobic a-keto acids, such as a-keto-y-methiolbutyrate (aKMB) and a-ketobutyrate
to their corresponding amino acids (Cooper, 1981 and refs, therein). However,
compounds 2.43 - 2.47 were not converted to the amino acids even in the presence o f 50
|ig o f GDH (see Experimental Section). Presumably, compounds 2.43 - 2.47 are too
large to be productively accommodated at the active site o f GDH. Although the idea that
compounds 2.43 - 2.47 might be substrates o f GDH proved to be untenable, the result
was useful nevertheless. Since compounds 2.43 - 2.47 did not interact with GDH, the
findings show that GDH could be used as an indicator enzyme to quantitate
transamination between GLU and the 3,4-conformationally restricted analogues o f a ketoglutarate.
Two o f the a-keto acid substrates o f LeuDH, namely a-ketoisovalerate and a keto-(3-methylvalerate, contain a hydrophobic branch point immediately adjacent to the
keto group and, therefore, bear some resemblance to compounds 2.43 - 2.47. However,
no activity could be detected when the natural substrates (i.e. a-ketoisocaproate) were
replaced by compounds 2.43 - 2.47 even when 50 pg o f enzyme was present in the
reaction mixture (see Experimental Section). Either the compounds are too large to fit
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into the active site or the additional carboxylic acid group is involved in a charge
repulsion at the active site.
In addition to phenylpyruvate, PDH exhibits some activity toward phydroxyphenylpyruvate, indolyl 3-pyruvate, otKMB and certain branched chain a-keto
acids (Asano, 1987). Therefore, it was reasoned that PDH has a somewhat large and
flexible active site and might show activity toward compounds 2.43 - 2.47. However, no
activity of PDH toward compounds 2.43 - 2.47 could be detected in the presence o f 50
|i.g o f enzyme within the assay mixture (see Experimental Section). The result was useful
because it showed that, again, since the compounds did not interact with the protein, PDH
could be used as an indicator enzyme to verify the formation o f phenylpyruvate in
transamination reactions between L-phenylalanine (PHE) and compounds 2.43 - 2.47.
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2. Analysis o f Compounds 2.43 —2.47 as Substrates ofLD H , GTK, AspAT, AlaAT and
KGDHC

As first shown by Meister fifty two years ago, LDH catalyzes the reduction o f
many a-keto acids with NADH to the corresponding a-hydroxy acid (Meister, 1950).
However, no reduction o f compounds 2.43 - 2.47 could be detected with LDH at enzyme
concentrations as high as 150 p.g per assay (see Experimental Section). The results show
that LDH could be used as an indicator enzyme in an assay to determine whether the
aK G analogues could participate in transamination reactions using L-alanine (ALA) as
the amine donor.
Compared to many other aminotransferases, GTK has a relatively broad
specificity. For example, it may be regarded as a fully reversible glutamine (methionine)
aromatic aminotransferase (Cooper, 1982). In addition, GTK catalyzes transamination
reactions with phenylglyoxylate (Cooper, 1982) and cyclohexylpyruvate (Cooper, 1982).
Moreover, the enzyme utilizes cystine, cystathionine and lanthionine as amino donor
substrates (Cooper, 1989 and ref. therein). These amino acids contain charged groups
distal to the binding site for the a-amino carboxyl grouping. Inasmuch as GTK can
accommodate large hydrophobic groups and distally charged groups at the active site it
was reasoned that compounds 2.43 - 2.47 might be substrates for GTK. As was found
with the dehydrogenases, however, no conversion to products was evidenced with GTK
(PHE as amino donor) for compounds 2.43 - 2.47 - even at an enzyme concentration o f
25 |ig per 50-pl assay mixture (see Experimental Section).
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AspAT exhibits some reactivity toward aromatic a-keto acids and L-a-amino
acids (Shrawder, 1972). Therefore, it was considered that the active site o f this enzyme
might be large enough to accommodate compounds 2.43 - 2.47. However, the ability of
these compounds to act as amino acceptors in a reaction catalyzed AspAT (or AlaAT)
was not observed - even at a concentration o f enzyme as high as 50 |ig per 200-p.l assay
(see Experimental Section). In a separate experiment, it was found that the 3,4conformationally restricted analogues o f a-ketoglutarate had no effect on malate
dehydrogenase (MDH). Therefore, the inability to detect AspAT-catalyzed
transamination between ASP and aK G analogues was not due to inhibition of the
coupling enzyme MDH. During the transamination reaction catalyzed by AspAT, the
active site becomes closed over (Saier, 1967). Presumably, the 3,4-conformationally
restricted analogues of a-ketoglutarate are too large to bind productively at the active site
o f AspAT or the active site cannot attain a closed conformation.
Finally, the ability o f compounds 2.43 - 2.4 7 to act as substrates o f KGDHC was
determined. No reduction o f NAD+ was noted under conditions in which KG was very
rapidly oxidatively decarboxylated, which indicates the inability o f compounds 2.43 —
2 .4 7 to act as substrates o f this enzyme complex.
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3. Preliminary Screening o f the CloneZyme™ Library

The recommended amino donor for screening o f potential a-keto acid substrates
for the CloneZyme™ library is L-glutamate (GLU). However, according to the suppliers
information, each of the enzymes in the CloneZyme™ library (i.e., AT-1 through AT-5)
is active with phenylalanine (PHE) as amino douor and L-methionine (MET) serves as a
good substrate o f all the enzymes in the library except AT-3. Therefore, by invoking the
principle o f microscopic reversibility, it was assumed that the enzymes AT-1, AT-2, AT4, and AT-S would catalyze transamination between PHE and aKM B (the a-keto acid
analogue of MET). The transamination product o f PHE (i.e., phenylpyruvate) is easier to
quantitate than is the transamination product of GLU (i.e., aKG). The PHE - aKMB
transamination procedure measures appearance of product (phenylpyruvate) rather than
disappearance o f substrate and is 2 . 0 to 2.5 times more sensitive than the procedure in
which loss of NADH absorbance is measured. In typical reactions, the product of the
transamination with aKG is coupled to an indicator enzyme which reduces the newly
generated a-keto acid with NADH. In preliminary experiments with PHE as amino
donor, aKMB as amino acceptor and AT-1 (or AT-5) as catalyst, it was established that
pyridoxal 5'-phosphate (PLP) is essential for maximal activity. Moreover, activity in the
presence o f 132 mM potassium borate buffer (pH 8.0) is considerably greater than the
activity in 100 mM potassium phosphate buffer (pH 7.4) or ammediol buffer (pH 9.0)
(data not shown). Based on the above considerations, procedures were devised as
convenient standard assays to screen the usefulness o f the CloneZyme™ library for the
transamination o f compounds 2.43 - 2.47. The enzyme (0.02 to 5 |xg) is incubated at
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45°C in a 50-|il reaction mixture containing 10 mM PHE, 5 mM aKMB, 20 |xM PLP and
132 mM potassium borate buffer (pH 8.0). After 2 to 10 min, 150 |il o f 1 N NaOH is
added and the absorbance due to phenylpyruvate-eno/afe is immediately determined at
320 nm (e ~ 16,000 cm '1). By using this procedure, high PHE - aKMB transaminase
activity was found with AT-1 and AT-5. Surprisingly, no activity was detected with AT-2
and AT-4, but the reasons were not investigated. When aKMB was replaced by aKG,
transamination was somewhat slower. The results obtained with AT-1 and AT-5 as
catalysts for PHE - aKM B/aKG transamination are shown in Table 3.1. [Note that in
order to prevent problems with evaporation, the well plate should be covered with a tight
fitting lid. Wells surrounding the “test” wells should be filled with water.]

Table 3.1. Transamination Between PHE and aKMB (or aKG) Catalyzed by AT-1 and
AT-5a

__________________pmol/min/mg o f enzyme_________________
q-Keto acid substrate__________AT-1 (n=3)___________________ AT-5 (n=3)_______
aKM B (5 mM)
a-K G (20 mM)
a-K G (40 mM)

0.51 ± 0.01
0.29 ± 0.01
0.60 ± 0.04

2.20 ± 0.02
0.76 ± 0.01
1.31 ± 0.05

a The 50-pl reaction mixture containing a-keto acid at the concentration shown, 10 mM
PHE, 20 |iM PLP, 132 mM potassium borate buffer (pH 8.0) and 2.5 pg o f either AT-lor
AT-5 (batch 1) was incubated at 45°C. After 2 min (aKMB as substrate) or 5 min (aketoglutarate as substrate), phenylpyruvate-eno/a/e formation was measured as indicated
in the experimental section.
hi preliminary experiments, it was found that AT-5 is several times more effective
than is AT-1 in catalyzing transamination reactions involving glutamate, phenylalanine,
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aKM B and the various aK G analogues (data not shown). A comparison o f GLU versus
PHE as an amino donor in the AT-5-catalyzed transamination o f aKMB is shown in
Table 3.2. The activity exhibited by AT-5 toward PHE in Table 3.2 is somewhat greater
than that shown in Table 3.1. This may be due to the fact that a different batch o f AT-5
was used in the experiment described in Table 3.1 (batch 1) from that used in the
experiment described in Table 3.2 (batch 2). Clearly, although the V™* values with PHE
and GLU are comparable, AT-S exhibits a much higher affinity toward PHE than toward
GLU. Based on the above findings, it was decided to use AT-1 and AT-5 (batch 2) and
10 mM PHE (or in some cases 320 mM GLU) as amino donor for screening 3,4conformationally restricted analogues o f a-ketoglutarate as a-keto acid substrates.
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4. Ability o f AT-5 to Catalyze Amine Transfer from PHE to Compounds 2.43 — 2.47

In preliminary experiments, compound 2.44 was chosen as the prototype to establish a
general procedure for measuring transamination o f compounds 2.43 - 2.47. Both AT-1
and AT-5 were found to catalyze transamination o f compound 2.44 (Figure 3.1). When 4
mM compound 2.44 was incubated in a 50-pl reaction mixture containing 10 mM PHE,
132 mM potassium borate buffer (pH 8.0), 20 (iM PLP and 20 pg o f enzyme at 45 °C for
lh, the amount o f phenylpyruvate formed (as measured as the enolate after addition o f
base) was 7.2 ± 0.2 and 24 ± 1.6 nmol (n = 3) for AT-1 and AT-5 (batch 1), respectively.
An additional experiment was also conducted in which phenylpyruvate formed after the

Table 3.2. Comparison o f PHE and GLU in the AT-5-Catalyzed Transamination o f a KMB®
L-Amino acid

pmol/min/mg o f enzyme

PHE (10 mM)
PHE (50 mM)
GLU (10 mM)
GLU (100 mM)
GLU (320 mM)
GLU (560 mM)

4.61 ±0.07
5.60 ±0.06
1.61 ±0.05
4.35 ±0.15
5.60 ±0.21
5.83 ±0.31

a The 50-pl reaction mixture containing L-amino acid at the indicated concentration, 5
mM aKMB, 20 |iM PLP, 132 mM potassium borate buffer (pH 8.0) and 0.2 pg o f AT-5
(batch 2) was incubated for 10 min at 45°C. Phenylpyruvate formed from PHE was
measured as its enolate after addition o f 150 pi o f 1 M NaOH. aK G formed from GLU
was measured by addition o f a 150-pl reaction mixture containing GDH, ammonia and
NADH. See the Experimental Section. aKMB exhibits slight activity with GDH and
therefore a correction was made for the drift in the blank lacking AT-5.
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1 h incubation was quantitated using PDH (see Experimental section). The amount o f
phenylpyruvate found using this procedure was 10.1 ± 0.3 and 22 ± 1.2 nmol (n = 3),
respectively. The two methods are in reasonably good agreement. Finally, it was shown
that the transamination reaction between 10 mM PHE and 4 mM compound 2.44 was
linear for 4 h at 45 °C when carried out in the presence o f either 20 pg o f AT-1 or 20 pg
of AT-S. These findings, together with those summarized in Tables 3.4 - 3.6, show that
at a concentration o f 4 mM, compound 3-1 is about 1 % as effective as 5 mM aKMB in
transamination reactions with PHE catalyzed by both AT-1 and AT-5. However, because
of the generally greater activity exhibited by AT-5 than AT-1 toward a-keto acids
(aKMB, aKG, compound 2.44), AT-5 was chosen for most studies involved in the
screening of the ability of compounds 2.43, 2.45,2.46 and 2.47 to participate in
transamination reactions. In addition to compound 2.44, compounds 2.43, 2.45,2.46 and
2.47 were found to be amine acceptors in the presence o f 10 mM PHE or 320 mM GLU
and 10 pg of AT-5 (batch 2) in the 50-pl reaction mixture (Table 3.4). In general, the
effectiveness of compounds 2.43 - 2.47 as substrates was similar whether PHE or GLU
was used as the amine donor.
In a separate set o f experiments, conditions were developed to characterize by
HPLC/MS the conformationally-restricted analogues o f L-glutamate generated by
transamination o f the 3 ,4-conformationally restricted analogues o f a-ketoglutarate with
PHE. Borate buffer is not recommended in these experiments because nonvolatile buffer
salts interfere with the electrospray ionization process and can cause contamination.
Ammonium acetate buffer (pH 7.5) was used in its place but this buffer is not optimal for
AT-5 activity. Therefore, to increase product formation, the temperature o f the assay
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mixture was increased from 45 °C to the optimal temperature o f 80 °C. Because the
heating chamber o f the well plate analyzer cannot be set to 80 °C, the reaction at this
temperature was performed at the bench. The 250-|il reaction mixture contained 10 mM
PHE, 20 pM PLP, 100 mM ammonium acetate buffer (pH 7.5), 10 pg o f AT-5 and
compounds 2.43 - 2.47. After a lh incubation at 80 °C in a screw-capped vial in a
heating block, 50 pi was transferred to a 96-well plate containing 150 pi 1 N NaOH and
the phenylpyruvate formed from transamination was measured as its enolate at 340 nm
(see the Experimental section). Table 3.3 shows the amount o f phenylpyruvate formed
per h/mg o f AT-5 at 80 °C for compounds 2.43 - 2.47. The relative transamination rates
between PHE and the 3,4-conformationally restricted analogues of a-ketoglutarate (as
measured by phenylpyruvate formation/h/mg of enzyme) are slightly different between
those shown in Table 3.3 (borate buffer, pH 8.0; 45 °C) and Table 3.4 (ammonium acetate

Table 3.3. Effectiveness o f Compounds 2.41 - 2.45 as Substrates o f AT-5 in the
Presence of 10 mM PHE

Compound

Cone. (mM)

pmol/h/mg o f enzyme (n=3)

2.43
2.44
2.45
2.46
2.47

4
4
25
25

0.84 ±0.08
1.23 ±0.08
0.26 ± 0 . 0 1
0.60 ± 0 . 0 2
0.42 ± 0.04

1

aThe 250-pl reaction mixture contained 10 mM PHE, 20 pM PLP, 100 mM ammonium
acetate buffer (pH 7.5), 10 pg o f AT-5 and compounds 2.43 - 2.47 (concentrations
indicated in Table). After a l-h incubation at 80°C in a screw capped vial in a heating
block, 50 pL was transferred to a 96 well plate containing 150 pi 1 N NaOH and
phenylpyruvate formed from PHE transamination was measured as its enolate. See the
Experimental section.
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buffer, pH 7.5; 80 °C). This slight discrepancy may be due in part to different activation
energies for transamination o f the various a-keto acids and different buffer conditions.
Nevertheless, for three 3,4-conformationally restricted analogues of a-ketoglutarate, the
yield o f transamination product was increased significantly at 80 °C relative to 45 °C
despite the fact that the buffer used at the higher temperature and for mass spectral
determinations was not optimal.
The remainder of the reaction mixture (i.e., 200 pi) was quenched by submersion
in a -1 0 °C salt bath. Aliquots (5 pi) of the solution were injected into the HPLC/MS
eluting at 1 ml/min. Two peaks were detected corresponding to PHE (m/z = 166) and
newly formed amino acid (m/z values indicated in Table 3.4). The 3,4-conformationally
restricted analogues o f a-ketoglutarate substrates and phenylpyruvate product were not
observed owing to poor ionization under the experimental conditions. In accordance with
the above observation, the mass spectrometer was set to the ion selective mode. The m/z
values monitored correspond to the amine donor (PHE, m/z 166) and the newly formed
amino acid (Figure 3.2). Representative examples o f the HPLC/MS (compound 2.44)
chromatogram and spectra are shown in Figures 3.2 and 3.3, respectively.
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Table 3.4. Structures o f Compounds 2.43 - 2.47 and Their Corresponding Amino Acids
Keto Acid
Structure
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The reaction mixture (same as described in the legend to Table 3.5) was incubated for lh (A) without of (B) in the presence of AT-5.
After removal of 50 fiL for the determination of phenylpyruvate, the mixture was cooled in a brine/ice bath and subjected to HPLC/MS
analysis with selected ion recording of phenylalanine (m/z 166) and conformationa)|y restricted GLU (m/z 228).

Figure 3.2: Selected ion recording of the amino acids in a reaction mixture in which PHE was transaminded with compound 2.41.
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Figure 3.3: Mass spectra corresponding to peaks 1 and 2 from Figure 3.2
(207 m/z corresponds to die (PHE - H+)(CH3CN) adduct).
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5. Survey o f a-Ketoglutarate Analogues as Inhibitors o f Dehydrogenases and
Aminotransferases

Some or all o f compounds 3-1 - 3-5 were found to be inhibitors of GTK, AspAT,
AlaAT or GDH (Table 3.5). Presumably, the compounds can bind non-productively
through their carboxyl groups. However, inhibition of GTK, AspAT, AlaAT and GDH by
compounds 2.43 - 2.47 is at best moderate. In this regard, it is interesting to note that
simple monocarboxylic acids are weak inhibitors o f AlaAT (Saier, 1967), and
dicarboxylate analogues of otKG are weak inhibitors o f AspAT (Velick, 1962).

Table 3.5: Inhibition o f Various Enzymes by Compounds 2.43 - 2.47

Cmpd

Cone. (mM)

None

GTK

[1 0 0

± 2]

AspAT

AlaAT

GDH

[100 ± 3]

[100 ± 3]

[100 ± 3 ]

2.44

4

96 ± 2

98 ± 4

75 ± 4 b

111 ± 13

2.43

8

92±2b

102 ± 3

83 ± 4 b

104 ± 4

2.47

I

93 ± 2 b

97 ± 1

62±5b

99 ±

2.45

20

73 ± lb

77 ± 4 b

47 ± 5b

91 ± 2 b

2.46

20

6 4± lb

42±3b

48 ± 2b

40 ± l b

6

aThe assay mixtures contained 10 mM PHE/5 mM ocKMB (GTK), 10 mM ASP/10 mM
otKG (AspAT), 20 mM ALA/10 mM OtKG (AlaAT), and 10 mM OtKG (GDH). Details
provided in the Experimental Section.
b Different from control (no addition) with p <0.05; n = 3 or 4.
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In addition, the effectiveness o f compounds 2.43 - 2.47 to act as inhibitors o f KGDHC
was tested. None o f the aK G analogues were found to inhibit KGDHC when added to the
standard assay mixture. Moreover, prior incubation o f KGDHC with 2-10 mM aKG
analogue for 30 min at 30 °C had no effect on enzyme activity.
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in . Summary

In summary, an exhaustive survey o f L-amino acid dehydrogenases and
aminotransferases as potential catalysts for the conversion of rigid aK G analogues to
rigid GLU analogues was carried out. This search led to the discovery that two enzymes
in the Sigma CloneZyme™ kit (AT-1 and AT-5) are capable o f catalyzing the conversion
o f compound 1 to its cognate L-amino acid in the presence of PHE. AT-S was the more
effective o f the two and was shown to be capable o f catalyzing transamination of all five
rigid aKG analogues with PHE or GLU as amino donor.
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IV. Conclusion

The fact that compounds 2.43 - 2.47 are not substrates o f major mammalian
enzymes that can utilize otKG/GLU turns out to be an important finding in regard to our
long-range goals. Because the 3,4-conformationally restricted analogues o f a ketoglutarate (2.43 - 2 .47) are not substrates o f GDH, AspAT or AlaAT, it is unlikely
that the corresponding amino acids will be substrates. The compounds will at best be
moderate inhibitors o f these enzymes. Thus, experiments designed to use the
corresponding amino acids as probes for GLU receptor/uptake systems will be unlikely to
suffer from complications due to interference with major ocKG/GLU-metabolizing
enzymes.
The fact that PHE is a good amine donor for AT-S should prove useful in the
isolation o f pure rigid GLU analogues. Because GLU and the rigid GLU analogues each
have one amino group and two carboxyl groups, separation by ion-exchange
chromatography may be difficult. On the other hand, separation o f PHE (one carboxyl)
from the rigid GLU analogues (two carboxyls) by ion-exchange chromatography should
be relatively easy. Moreover, the co-product o f the transamination reaction (i.e.,
phenylpyruvate) is strongly absorbed by charcoal whereas the rigid GLU analogues are
not expected to bind strongly.
The present results show that it is possible to use thermostable aminotransferases
to bring about transamination o f some very bulky a-keto acids. As noted above, GTK is
able to catalyze transamination o f some remarkably elongated amino acids containing
charged groups distal to the amino acid portion that binds to the active site. This finding
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suggests that the active site is groove-like and relatively open-ended. However, the
present findings suggest that there is a limit to the width (i.e., bulkiness) o f the a-keto
acid or a-amino acid that can bind within the active site “groove”.
To our knowledge, the aminotransferase that catalyzes transamination reactions
with the largest substrates is 7, 8 -diaminopelargonic acid aminotransferase (Equation 3.2)
(Eisenberg, 1971; Stoner, 197S). This aminotransferase, however, is unusual on two
counts. First, the “oxo” substrate (i.e. 7-oxo-8-aminopelargonic acid) is not an a-keto
acid. Secondly, the amine donor is 5-adenosyl-L-methionine. This amino acid is
obviously much larger than the more common amino donors in transamination reactions
(e.g. GLU, ALA, ASP). Moreover, in solution, there is no restriction to rotation at the 3
and 4 positions in 5-adenosyl-L-methionine. In the present work, we showed that AT-S
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Figure 3.4. Transamination o f very bulky substrates

is able to catalyze some remarkable transamination reactions with conformationally
restricted OtKG analogues that contain large, bulky groups at the 3 - and 4 carbons. To
our knowledge, compound 3.3 is by far the largest a-keto acid with bulky substitutions at
the 3- and 4 carbons that has been demonstrated to undergo an enzyme-catalyzed
transamination. Our findings indicate that AT-5 must have a large and flexible active site.
Thus, the enzyme may be o f general utility in the synthesis o f bulky amino acids from
their corresponding a-keto acids.
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AT-5 may also prove useful in other regards. Each o f the compounds shown in
Table 3.5 is composed o f a mixture o f stereoisomers. Because o f the flexibility o f the
active site, AT-5 may be able to accommodate all o f the stereoisomers at its active site.
Thus, the synthesis o f a number o f diastereoisomers o f conformationally restricted
glutamates may be possible using AT-5.
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V. Experimental

1. Enzymes and Reagents

Crystalline pig heart cytosolic aspartate aminotransferase (AspAT; 270 U/rng of
protein at 37°C; suspension in 2 M ammonium sulfate), crystalline pig heart alanine
aminotransferase (AlaAT; 80 U/mg o f protein at 37°C; suspension in 2 M ammonium
sulfate), beef liver glutamate dehydrogenase (GDH; 50 U/mg o f protein at 37°C in 50%
glycerol), rabbit muscle lactate dehydrogenase (LDH; type XXXDC; 720/U mg o f protein
at 37°C in 50% glycerol), mitochondrial pig heart malate dehydrogenase (MDH; 910
U/mg o f protein at 37°C in 50% glycerol), pig heart a-ketoglutarate dehydrogenase
complex (KGDHC; 0.8 U/mg of protein at 30°C in 50% glycerol), pyridoxal 5'-phosphate
(PLP), NADH, ammonium acetate (NH4OAC), ADP, L-aspartate (ASP), L-alanine (ALA),
L-phenylalanine (PHE), monosodium L-glutamate (GLU), phenylpyruvate and the
sodium salts of a-ketoisocaproate, a-ketoglutarate (aKG) and a-keto-y-methio lbutyrate
(aKMB) were obtained from Sigma Chemical Co. (St. Louis, MO). An aminotransferase
library kit (CloneZyme™) was also obtained from Sigma (Warren 1998; 1999; 2000).
This kit consists o f five unique thermostable aminotransferases (60 to >95% purity)
supplied as lyophilized powders together with a solution o f 660 mM potassium borate
buffer (pH 8.0). Each enzyme (1 mg o f protein per vial) was dissolved in 1 ml o f 10 mM
potassium phosphate buffer (pH 7.4) containing 20% glycerol (v/v). For simplicity, the
aminotransferases designated as AMN-001-01 through AMN-001-05 by the manufacturer
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are referred to as AT-1 through AT-5. AT-5 was also purchased in bulk (500 mg)
directly from the Diversa Corporation (San Diego, CA). In preliminary experiments with
AT-1 and AT-5, the enzymes were found to be stable in solution for one week at 4°C.
However, the two enzymes lost all activity by 2 weeks. Storage at room temperature in
the glycerol/phosphate buffer did not improve the stability. L-Leucine dehydrogenase
(LeuDH; lyophilized powder with a specific activity o f 38 U/mg o f protein at 37°C) was
obtained from Toyobo Co., LTD., Osaka, Japan. The concentrations o f solutions o f AT-1
through AT-5 and specific activities o f the commercial enzymes were verified by means
o f standard assay procedures (data not shown). Cytosolic glutamine transaminase K
(GTK) o f rat kidney was purified essentially as described by Cooper (Cooper, 1978). The
preparation has a specific activity at 37 °C o f 5 U/mg o f protein (PHE - aKMB
transaminase assay) (Cooper, 1978). L-Phenylalanine dehydrogenase from Sporosarcina
ureae (PDH; crystalline suspension in 3 M ammonium sulfate with a specific activity in
the direction o f PHE oxidation o f ~100 U/mg o f protein at 25°C (Asano, 1987) was a
generous gift from Professor Yasuhisa Asano (Toyama Prefectural University, Japan). A
unit o f enzyme activity is defined as the amount of enzyme that catalyzes the formation
o f one iimoi o f product per minute at the specified temperature.
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2. Enzyme assays

To test the aK G analogues as substrates o f various L-amino acid dehydrogenases,
the a-keto acid was dissolved in a 200-jil reaction mixture containing 100 mM Tris-HCl
buffer (pH 8.4), 0.1 mM NADH, 40 mM ammonium sulfate, 0.1 mM ADP and
dehydrogenase (1 - SO jig). The rate o f decrease in absorbance at 340 nm due to loss o f
NADH (e = 6,230) and concomitant with the reductive amination o f a-keto acid was
continuously recorded at 37°C. The rates o f reductive amination were compared to those
obtained with S mM standard a-keto acid substrates, namely aK G (for GDH), a ketoisocaproate (for LeuDH) or phenylpyruvate (for PDH) in place o f the aKG
analogues. To test the aK G analogues as substrates o f LDH, the a-keto acid was
dissolved in a 200-p.l reaction mixture containing 100 mM potassium phosphate buffer
(pH 7.4), 0.1 mM NADH, and LDH (1 - 150 pg). The rate o f disappearance of NADH at
21°C was compared to that obtained with a standard assay mixture containing 5 mM
pyruvate in place o f the aKG analogues. To test the aK G analogues as substrates of
GTK the a-keto acid was dissolved in a 50-|il reaction mixture containing 10 mM PHE,
100 mM ammediol (2-amino-2-methyl-1,3-propan-diol) buffer (pH 9.0) and 25 |ig o f
enzyme. After incubation at 37 °C for 1 h, 150 |il o f 1 N NaOH was added and the
absorbance at 320 nm was determined immediately in a 96-well plate analyzer and
compared to that obtained with 5 mM aKMB in place o f the otKG analogues. The
extinction coefficient o f phenylpyruvate-eno/afe under these conditions is 16,000 cm '1.
In some experiments, the absorbance at 340 nm was determined (extinction coefficient o f
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phenylpyruvate-ewo/a/e at this wavelength = 10,400 cm '1). To test the aK G analogues as
substrates o f AspAT, the a-keto acid was dissolved in a 200-pi reaction mixture
containing 20 mM ASP, 100 mM potassium phosphate buffer (pH 7.4), 0.1 mM NADH,
1 jig o f MDH and 1-50 pg o f AspAT. The rate of disappearance o f NADH at 2l°C was
compared to that o f a standard assay mixture containing 10 mM aKG in place o f the
aKG analogues. To test the aKG analogues as substrates of AlaAT, the a-keto acid was
dissolved in a 200-pl reaction mixture containing 20 mM ALA, 100 mM potassium
phosphate buffer (pH 7.4), 0.1 mM NADH, 1 pg o f LDH and 1-50 pg o f AlaAT. The rate
of disappearance o f NADH at 21°C was compared to that of a standard assay mixture
containing 10 mM aK G in place o f the aKG analogues. To test the aKG analogues as
substrates of KGDHC, the standard 200-pl assay mixture (Park, 1999) was used except
that aKG was replaced by the a-keto acid analogue. The rate o f increase o f absorbance
at 340 nm due to reduction of NAD+ to NADH at 30°C was compared to that obtained
with aKG. For all enzyme assay determinations, blanks lacked enzyme.
In a separate series of experiments, assays were developed for the
aminotransferases in the Sigma CloneZyme™ kit as a prerequisite for the search for
enzymes within the kit capable of catalyzing transamination of compounds 3-1 - 3-5
(Figures 1 and 2). Although the enzymes in the Sigma kit have high temperature optima
(80 °C for A T -1,2,3 , and 5; 50 °C for AT-4) preliminary experiments were conducted at
45 °C [maximum temperature setting in the well plate analyzer]. The development o f the

assays (final volume = 50 pi) with either PHE or GLU as amino donor is described in the
Results and Discussion section. The product o f the transamination o f GLU (i. e., aKG)
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was quantitated with GDH. To the 50-|il reaction mixture was added ISO p.1 o f a solution
containing 0.05 mM NADH, 0.1 mM ADP, 40 mM ammonium sulfate and 10 pg o f
GDH. The disappearance o f NADH due to reductive amination of aK G was monitored at
340 nm at room temperature. The amount of aKG formed in the initial 50-p.l reaction
mixture was calculated from the A absorbance relative to a control reaction mixture
lacking thermostable aminotransferase. Reductive amination o f aKG was complete in
about one minute. The product of the transamination o f PHE (i.e., phenylpyruvate) was
routinely determined as its enolate as described above. However, in some cases,
phenylpyruvate was also determined with PDH. In this case, the 50-pl reaction mixture
was treated with a 150-pi solution containing 0.0S mM NADH, 40 mM ammonium
sulfate and 10 pg o f PDH. The disappearance of NADH due to reductive amination o f
phenylpyruvate was monitored at 340 nm at room temperature. Reductive amination of
phenylpyruvate was complete in about one minute. The amount of phenylpyruvate
formed in the initial 50-pl reaction mixture was calculated from the A absorbance relative
to a control reaction mixture lacking thermostable aminotransferase.
Enzyme activities are reported as the mean ± S. E. M.
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3. Apparatus

Spectrophotometric assays were carried out in either a SpectraMax or VersaMax
96-well plate analyzer (Molecular Devises). High performance liquid
chromatography/mass spectroscopy (HPLC/MS) was carried out using a MicroMass LCT
mass spectrometer running in the positive ion mode. The HPLC was performed with a
Waters 2790 pump on an (R, R) WHELK-0 1 column (5pM, 25 cm X 4.6 mm i.d.)
(REGIS Technologies, Inc. Morton Grove, IL, USA), 5 pi injection with a (low rate of
lml/min (50/50 acetonitrile:water v/v containing 1% v/v formic acid) with post column
splitting to allow 180 pl/min of eluent into the MS source. Analytes o f interest were
observed as the protonated species yielding mass spectral peaks corresponding to MT+1.
In many cases, analytes were also observed as the protonated species clustered
with acetonitrile yielding mass spectral peaks corresponding to M+ + 42.
The mass spectrometer settings were: capillary voltage = 2500 V; sample cone = 4 V;
extraction cone = 4 V; Rf lens = 150 V; desolvation temperature = 400 °C; source
temperature = 150 °C; gas flow (cone) ~ 2 - 10 1/hr; desolvation ~ 6 5 0 1/hr.
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4. ce-Ketoglutaric Acid Analogues

The analogues tested were: 6-oxaiyl-cyclohex-3-enecarboxylic acid (2.43); 3,4dimethyl-6-oxalyl-cyclohex-3-enecarboxylic acid (2.44), 3-oxalyl-bicyclo[2.2.1]hept-5ene-2-carboxylic acid; and (2.45), 3-oxalyl-bicyclo[2.2.2]oct-5-ene-2-carboxylic acid
(2.46) and 9,10-dihydroanthraceno-3,10-[3,4-(2-oxo)]-glutaric acid (2.47). Compounds
2.43 - 2.47 were prepared as described in Chapter 2. Stock solutions o f the a-keto acids
at 40 mM (compound 2.43), 20 mM (compound 2.44), 100 mM (compounds 2.45 and
2.46) and S mM (compound 2.45) were made up in distilled water and stored frozen at 20 °C.
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Chapter 4: Evaluation of trans-3,4-Conformationally Constrained Glutamate
Analogues (2.31,2.32,233,2.34) as Excitatory Amino Acid Transport Inhibitors

I. Introduction

The conformationally constrained analogues of glutamate synthesized in Chapter
2 have many useful features in the field o f glutamate pharmacology. These compounds
are very similar to that o f known glutamate transport inhibitors such as 2 , 4-PDCs and LCCGs (Chapter 1). The constrained analogues may prove beneficial in locking the
glutamate backbone into a conformation that may interact specifically with one
transporter. For example, if a compound is found that is specific for EAAT2, it is
possible preferentially block the transport o f glutamate through that protein and study the
biological implications o f this state. A potent and selective inhibitor may give valuable
insight into the mechanisms and actions o f specific that transporter.
Specifically, the conformationally constrained analogues o f glutamate 2.27,2.29,
23 2 - 2.35 (Figure 4.1) were screened as potential inhibitors o f the sodium dependent
excitatory amino acid transporters 2 (EAAT2) and 3 (EAAT3), the chloride dependent
glial cystine/glutamate exchanger system Xc\ and the glutamate vesicular transport system
(VGLUT). These transporters are responsible for the regulating o f synaptic glutamate
concentrations and if a transporter is found that the analogues are specific for, there is
high potential for scientific and therapeutic use.
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Figure 4.1. Glutamate analogues tested as potential transport inhibitors.

In reference to Chapter 1, transport assays have demonstrated that L-trans-2,4PDC acts as a substrate o f the excitatory amino acid transporter subtypes EAATl-4 and
as a non-substrate inhibitor of the EAAT5 subtype (Arriza, 1997; 1994; Fairman, 1995;
Koch, 1999). Similarly, the individual stereoisomers of the l -CCG s also exhibit
interesting activities at these transporters. For example, l-CCG-II and l-CCG-III (Figure
1.4) have both been reported to block the uptake o f [3H]-L-glutamate into synaptosomal
preparations (Robinson, 1993). More detailed studies using cellular expression systems
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have demonstrated that l-CCG-IH potently inhibits EAAT1, EAAT2, and EAAT3, while
L-CCG-IV preferentially inhibits EAAT2 (Shimamoto, 1998; Yamashita, 1995).

II. Biological Activity

The well characterized transport inhibitor o f EAAT2, dihydrokainate (Figure 4.2;
Bridges, 1991) is used as a standard for comparison o f inhibition o f glutamate transport.
The natural substrate for the transporter, L-glutamate is
also included to as a standard reference for the inhibition
of EAAT3.
H
Figure 4.2. Dihydrokainate

Testing of the potential inhibitors o f EAAT2 was
conducted by quantifying the ability o f the analogues to

attenuate the uptake of [3H]-D-aspartate into synaptosomes prepared from rat forebrain.
Under the assay conditions employed, the Km value for the uptake o f [3H]- d -aspartate
into the synaptosomes was 4.9 ± 1 pM (Koch, 1999). While EAAT2 is generally
considered a glial transporter, previous studies have demonstrated that synaptosomal
preparations clearly exhibit a pharmacological profile consistent with EAAT2 (Koch,
1999). As reported in Table 4.1, compounds 2.27,2.32, and 2.34 markedly reduced
uptake below Control values, hi particular, 2.32 and 2.34 proved to be comparable in
activity (i.e., 62% and 65% inhibition, respectively) to dihydrokainate (DHK), a wellcharacterized selective EAAT2 inhibitor. Further, as these analogues were tested as a
stereoisomeric mixture, it is quite possible that the observed activity may reside in a
single species that would, consequently, possess considerably greater activity. The
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Table 4.1. Activity o f conformationally constrained glutamate analogs (2.27,2.29,2.322.35) as transport inhibitors

Compound
(conc.)

2.27 (250 pM)
(500 pM)
2.29 (250 pM)
(500 pM)
2.32 (250 pM)
(500pM)
2.33 (250 pM)
(500 pM)
2.34 (250 pM)
(500 pM)
235 (250 pM)
(500 pM)
DHK (250 pM)
l-GIu (25 uM)

Synaptosomal
C6 Cellular
SNB-19 Cellular Synaptic Vesicular
(EAAT2).
(EAAT3).
(xcO-Uptake o f 3H(VGLUT).
Uptake of 3H-D- Uptake of 3H-Dl-GIu (IOO uM )
Uptake of 3H-dAsp (5 pM)
Asp (25 pM)
Glu (250 pM)

53 ± 6 (n =3)

103 ± 2 (n =3)
93 ± 2 (n =3)

89 ± 7 (n =3)

97 ± 3 (n =3)

103 ±9 (n=3)

95 ± 3 (n =3)

101 ±7 (n =3)

77 ± 7 (n =3)

96 ± 3 (n =3)
85 ± 5 (n =3)

38 ± 2 (n =3)
71 ± 14 (n =3)

99 ± 5 (n =3)
100 ± 1 (n=3)

104 ± 8 (n =3)
104 ± 4 (n =3)

70 ± 4 (n =3)
97 ± 3 (n =3)

88 ± 5 (n =3)

87 ± 9 (n =3)
-

88 ± 5 (n =3)

35 ± 5 (n =3)
22 ± 3 (n =3)
28 ± 5 (n > 3)

93 ± 5 (n =3)
-

-

Compounds were evaluated at the concentrations indicated as inhibitors of several different
glutamate transport systems. Na-dependent uptake of [3H]-D-aspartate into synaptosomes (Koch,
1999) and C6 glioma cells (Palos, 1996) was used to evaluate activity at EAAT2 and EAAT3,
respectively. Cl-dependent uptake of [3H]-L-glutamate into SNB 19 (Ye, 1999; Martin, 1979) was
used to determine activity at system xc\ while the ATP-dependent uptake of [3H]-L-glutamate by
isolated synaptic vesicles (Maito, 1985) was used to quantify activity at the vesicular glutamate
transporter. Values shown are reported as mean % of Control ± SEM (n > 3). Dihydrokainate
(DHK) and L-glutamate (L -Glu) are included as a reference for inhibition of EAAT2 and
EAAT3. Control rates of uptake (pmol/min/mg protein) were as follows: synaptosomes, 1827 ±
184 (n = 8); C6 cells, 26 ±1 (n = 8); SNB 19 cells, 629 ± 23 (n= 7); synaptic vesicles, 3328 ± 373
(n = 5). All values have been corrected for non-specific uptake.
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potential cross reactivity of the analogues was also assessed at: a) EAAT3, by quantifying
the uptake o f [3H]-D-aspartate into rat C6 glioma cells (Palos, 1996); b) the system xc'
glutamate/cystine exchanger, by quantifying the uptake of [3H]-L-glutamate into SNB-19
human astrocytoma cells (Ye, 1999; Martin, 1979) and c) the vesicular glutamate
transporter, by quantifying the uptake o f [3H]-L-glutamate into synaptic vesicles prepared
from rat forebrain (Carrigan, 1999; Naito, 1985) To provide an indication of activity at
these other systems, the Km values for the respective substrates have been determined to
be: 9 ± 2 pM (n = 9) for D-aspartate at EAAT3 in C6 cells, 111 ± 10 pM (n = 4) for L glutamate at system xc' in SNB-19 cell, and 2.8 ± 0.2 mM for L-glutamate at the
vesicular transporter in isolated synaptic vesicles. In each instance (Table 4.1), the
compounds exhibited little or no activity at these alternative transporters. The activity
and selectivity shown by inhibitors 2.32 and 2.35 at EAAT2 suggests a well-defined
steric relationship. Analogs 2.32 and 2 3 5 differ from analogs 2 3 3 and 2 3 4 in the
incorporation of two methyl groups and insertion o f a ring methylene yet 2 3 3 and 2.34
show significantly lower activity than analogs 2.32 and 2 3 5 . Molecular modeling
studies and the separation of the stereoisomers and testing each one individually will
even further refine the pharmacophore model of the EAAT2 transport binding site. For
the most selective and potent analogues, the assay mixture contained four stereoisomers.
If these were to be tested individually, their potency could be as much as four times what
we have seen in the assays. Molecular modeling o f the inhibitors against the most potent
and selective EAAT2 inhibitor, DHK, would also provide good insight into the elements
o f the molecules required o f inhibition at EAAT2. Taken together, these results identify
the conformationally restricted glutamate analogs as a new structural class o f compounds
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that should prove useful in developing novel probes o f EAAT2 and help to further
delineate a pharmacophore model for the substrate-binding site on the transporter protein.
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III. Experimental

1. EAAT2 uptake (Koch, 1999)

Na+-dependent uptake o f [3H]-D-aspartate (Dupont NEN, Boston, MA) into
synaptosomes was quantified as follows. Synaptosomes were prepared from forebrains
of male Sprague-Dawley rats (200-300 g) using a discontinuous Ficoll gradient. The
synaptosomal pellet was suspended in assay buffer (see below) at a final concentration of
approximately 0.2 mg protein/mL. Uptake o f [3H]-D-aspartate through the high-affinity,
sodium-dependent EAAT2 was quantified in assay buffer containing 128 mM NaCl, 10
mM glucose, S mM KCl, l.S mM NaH 2P0 4 , 1 mM MgS0 4 , 1 mM CaCh, and 10 mM
Tris (pH 7.4). Following a preincubation (S min, 25 °C), uptake was initiated by the
simultaneous addition of [3H]-D-aspartate (final concentration 5 pM) and the
conformationally constrained glutamate analogues. Uptake was allowed to proceed for 2
min, after which time the reaction was stopped by the addition o f ice-cold assay buffer (6
mL) and rapidly filtered on Whatman GF/F glass fiber filters. Following a rinse with icecold buffer (6 mL), the radioactivity retained on the filters was quantified by liquid
scintillation counting. All values were corrected for background by subtracting [3H]-daspartate accumulated at 4 °C and are reported as mean ± SEM. Previous experiments
have demonstrated that under these conditions, uptake is sodium-dependent and linear
with respect to both protein content and time. Protein concentrations were determined by
the Pierce BCA (bicinchoninic acid) assay.
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2. EAAT3 (Palos, 1996) and system xc' uptake (Ye, 1999; Martin, 1979)

The uptake o f (a) [3H]-L-glutamate or (b) [3H]-D-aspartate into cultured cells was
quantified as follows. Individual wells, after removal o f culture media, were rinsed three
times and pre-incubated in 1 mL HEPES buffered (pH 7.4) Hank’s balanced salt solution
(HBHS) at 30 °C for 5 min. The HBHS was altered by ionic substitution to isolate the
Na+ and Cl' -dependent transport systems. The buffers contained: (a) CT-dependent
(EAAT3): 137.5 mM Choline Cl, 5.36 mM KC1, 0.77 mM KH2P 0 4, 0.71 mM
MgS04.7H20 , 1.1 mM CaCl2, 10 mM D-glucose, 10 mM HEPES or (b) total Na~ and Cr
-dependent (system xc~): 137 mM NaCl, 5.1 mM KC1,0.77 mM KH2P 0 4, 0.71 mM
MgS04.7H20 , 1.1 mM CaCl2, 10 mM d -glucose, 10 mM HEPES and uptake was
initiated by aspiration of the preincubation buffer and the addition o f a 500 |il aliquot of
the appropriate transport buffer containing (a) [3H]-L-glutamate (100 pM) or (b) [3H]-Daspartate (25 pM). A 500 pi aliquot o f transport buffer contained both the (a) [3H]-Lglutamate, (b) [3H]-D-aspartate and conformationally constrained glutamate analogues
(50, 500 pM, final concentration) to ensure simultaneous addition. Following a 5 minute
incubation at 30 °C, the assays were terminated by three sequential 1 mL washes with ice
cold buffer and then the cells were dissolved in 1 mL of 0.4 M NaOH for 24 hours. An
aliquot (200 pi) was then transferred into a 5 mL glass scintillation vial and neutralized
with the addition o f 5 pi glacial acetic acid followed by 3.5 mL scintillation fluid to each
sample. Incorporation o f radioactivity was quantified by liquid scintillation counting.
Values reported are corrected for non-specific uptake by subtracting the amount of
radioactive substrate accumulation at 4 °C. Previous experiments have demonstrated that
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under these conditions, uptake is sodium-dependent and linear with respect to both
protein content and time. Protein concentrations were determined by the Pierce BCA
(bicinchoninic acid) assay.
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3. VGLUTuptake (Corrigan, 1999; Naito, 1985)

Vesicular glutamate transport (VGLUT) was quantified in a pH 7.4 solution containing 5
mM HEPES, 2 mM ATP, 4 mM KC1,4 mM MgCh and [3H]-L-glutamate (0.25-8 mM).
The assays were initiated by the addition of [3H]- L -glutamate ± inhibitors (0.01-5 mM)
to the synaptic vesicles (total vol. 100 pi, 0.1 mg protein). Uptake was allowed to
proceed at 30 °C for 1.5 min, after which the vesicles were collected by vacuum filtration
through Millipore HAWP filters. The filters were rinsed twice, after which the retained
radioactivity was quantified by liquid scintillation counting. Non-specific uptake was
determined in the absence o f ATP.
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IV. Collaborators

All o f the pharmacological data was collected in collaboration with Todd Seib
(EAAT2), Fred Rhoderick (EAAT3), Brady Warren (system Xc*) and Kimberly Cybulski
(VGLUT) under the advisement of Dr. Richard J. Bridges, Department of Pharmaceutical
Sciences, COBRE Center for Structural and Functional Neuroscience, The University o f
Montana, Missoula, MT 59812, USA.
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Chapter 5: Conclusions and Future Directions

I. Conclusions

The goal o f this project was to develop a novel synthetic route to
conformationally constrained glutamate analogues using a novel dienophile to explore its
reactivity in a normal electron demand Diels-Alder sequence. Exploration o f the use o f a
chemical and/or enzyme mediated reductive amination. The goals that were achieved
are:
•

It was shown that dimethyl 4-oxoglutaconate is a highly reactive dienophile in the
normal electron demand Diels-Alder reaction;

•

dimethyl 4-oxoglutaconate underwent formal Diels-Alder reactions with
azadienes to form heterocyclic glutamate analogues;

•

several methods were found that chemically transform the ketone o f the DielsAlder adducts into an amino group;

•

the conformationally-constrained analogues o f glutamate were synthesized by the
reaction o f the Diels-Alder adducts with N, N-dimethylhydrazine to form the
hydrazones which were subsequently reduced using sodium hydrosulfite

•

conformationally-constrained analogues o f 2-oxoglutarate were synthesized and a
procedure for their purification was developed

•

a broad survey o f the 2-oxoglutarate analogues as substrates of aminotransferases
and dehydrogenases was performed
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•

an aminotransferase was found that converts the conformationally constrained
analogues of 2-oxoglutarate to glutamate analogues

•

two conformationally constrained analogues o f glutamate were found to be potent
and selective inhibitors o f EAAT2 and inactive at EAAT3, system x / and
VGLUT
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II. Future directions

It is important to expand the versatility o f the Diels-Alder reaction with DOG as a
dienophile. The resultant Diels-Alder adducts are excellent precursors for the synthesis
o f conformationally constrained glutamate analogues that are not normally accessible. A
broadened panel o f Diels-Alder adducts should include more regiodirecting dienes and
the interpretation of their reactivity with DOG in both percent yield and regioselectivity.
With the utilization of DOG as the dienophile, the product mixture of the reaction
has at least one pair o f enantiomers which, in turn, are inseparable by traditional
chromatographic techniques. If the synthesis was modified to bear the chiral alcohol
menthol in the initial ester formation followed by bromination and dehydrohalogenation,
a chiral dienophile will be generated (Figure S.l). This new dienophile can then be
assessed for reactivity and stereoselectivity that goes above and beyond the retention o f
regiochemistry about the olefin bond. This dienophile has the potential for controlling
the enantioselectivity o f the Diels-Alder reaction as well as producing a product pool that
will contain chromatographically resolvable mixture o f stereoisomers. Once resolved,
each stereoisomer may be used in the hydrazone formation and reductive amination
producing a new resolvable set o f amino esters or lactam esters. Further, each resolved
amino ester or lactam ester can be saponified and tested as an individual stereoisomer o f
a conformationally constrained glutamate.
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Figure 5.1: Synthesis of dimenthol 4-oxoglutaconate

With the testing o f individual stereoisomers being a very worthwhile cause, there
a number of ways in which the stereoisomers can be resolved to obtain optically pure
constrained glutamate analogues. For example, there are two stereoisomeric products of
the reaction between 2 ,3-dimethyl-1 ,3-butadiene and DOG (Figure 5.2). Once the
hydrazone is formed and reduced to produce the lactams, there are four stereoisomeric
products. In either circumstance, it may be possible to transesterify with a chiral alcohol
(S-2-butanol, for example) to form chromatographically separable stereoisomers (Figures
5.2 and 5.3).
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As is shown in Table 4.1, two stereoisomer mixtures o f conformationally
constrained glutamate analogues (2.31 and 2.33) were shown to be selective and
modestly potent inhibitors o f EAAT2. Therefore, if the individual stereoisomers can be

Initial Diels-Alder
product mixture

S-2-butanol, NaH
HPLC Separation

co 2ch3

Figure 5.2: Functionalization and separation o f keto diesters

obtained and tested, there is a distinct possibility that a single stereoisomer will possess
considerably greater activity.
The reactivity o f the a , P-unsaturated N, N-dimethylhydrazones with DOG to
form a new class of conformationally constrained glutamate analogues will also be of
great interest With the distinct regiochemistry o f the reaction, the products that can be
accessed by the reductive cleavage o f the hydrazine bond followed by saponification o f
the esters are much fewer than that o f a reaction under no regiocontrol. This is a very
valuable method for the synthesis o f a vast number o f conformationally constrained
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glutamate analogues with minimal synthetic variation, i.e. a large number o f analogues
can be accessed by simply varying the a , [3-unsaturated aldehydes purchased for the
synthesis o f the a , (3-unsaturated N, N-dimethylhydrazones to be used as azadienes.
The initial studies into the synthesis of 4-oxoglutamate (Chapter 2) produced
mixed results. The desired target molecule has yet to be synthesized, however, the
intermediate structures may be o f potential benefit in the study o f conformationally
constrained glutamate analogues. Figures 5.4 and 5.5 illustrate some potential glutamate
analogues that can be accessed from pyrrolidone (2.41) formed by the 1,4-addition o f
benzylamine to DOG. As depicted in Figure 5.4, the proposed synthesis of the glutamate
analogue DL-f/rreo-p-benzyloxyglutamate (TBOG), which incorporates similar features
to the well known competitive, non-transportable inhibitor o f glutamate transporters, d lr/ireo-P-benzyloxyaspartate (TBOA), is outlined. Another possible addition to the
chemistry proposed in figures 5.4 and 5.5 is that the chiral amine R-(+)-amethylbenzylamine can be used as the nucleophilic addition reagent and the products
obtained will possess the potential for chromatographic, stereoisomer resolution.
The utility o f the synthetic strategy o f this thesis has much potential for further
exploration in the field of medicinal chemistry. The synthesis o f novel analogues o f
glutamate is o f great potential for experimental and therapeutic use in the glutamate
neurosystem.
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Figures 5.3: Proposed synthesis o f DL-f/treo-P-benzyloxyglutamate
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